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There are no physicists in the hottest parts of hell,
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This is obviously impossible.
Richard Davisson
Para todos os que me têm aturado . . .

Index
List of Figures vii
List of Tables ix
List of Acronyms and Abbreviations xi
Visão global xiii
Sumário . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xiii
Objectivos desta dissertação . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xiii
Esboço deste trabalho . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xiii
Overview xv
Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xv
Objectives of this dissertation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xv
Outline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xv
I Introduction 1
1 Physics Background 3
1.1 Spallation process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.1.1 Compound-nucleus reaction . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.1.2 Direct reaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.2 Reaction probability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.2.1 Thick target yields . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.3 Neutrons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1.3.1 Neutron-matter interactions . . . . . . . . . . . . . . . . . . . . . . . . 7
1.3.2 Neutron energy ranges . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.3.3 Neutron sources . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.4 ICNAS cyclotron . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.4.1 Energy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.4.2 Beam density and dispersion . . . . . . . . . . . . . . . . . . . . . . . . 10
2 Neutron Applications 13
2.1 Neutron capture therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2.1.1 Principles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2.1.2 Compounds for NCT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.1.3 Neutron beamline requirements . . . . . . . . . . . . . . . . . . . . . . 21
2.1.4 Radiobiological considerations . . . . . . . . . . . . . . . . . . . . . . . . 23
2.1.5 Challenges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
i
ii Index
2.2 Neutron imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.2.1 Principles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.2.2 Comparison with other imaging modalities . . . . . . . . . . . . . . . . . 27
2.2.3 Neutron beamline requirements . . . . . . . . . . . . . . . . . . . . . . . 28
2.2.4 Detectors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2.2.5 Applications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.3 Neutron activation analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
II Simulation studies 37
3 Validation of Geant4 39
3.1 Validation of (p,n) reactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.1.1 Setup . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
3.1.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
3.1.3 Considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
3.2 Validation of (d,n) reactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.2.1 Setup . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.2.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.2.3 Considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.3 Verification of californium-252 decay . . . . . . . . . . . . . . . . . . . . . . . . 52
3.3.1 Setup . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
3.3.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
4 Implementation viability 57
4.1 Cyclotron beam energy and dispersion . . . . . . . . . . . . . . . . . . . . . . . 57
4.1.1 Setup . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
4.1.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
4.2 Thick target optimization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
4.2.1 Reaction (p,n) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
4.2.2 Reaction (d,n) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
4.3 Cyclotron-based neutron beamline . . . . . . . . . . . . . . . . . . . . . . . . . 62
4.3.1 Setups . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
4.3.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
4.4 Californium-252-based neutron beamline . . . . . . . . . . . . . . . . . . . . . . 75
4.4.1 Setup . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
4.4.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
4.5 Implementation and operational costs . . . . . . . . . . . . . . . . . . . . . . . 79
III Conclusions and future work 81
5 Conclusions and future work 83
IV Appendices and bibliography 85
A Stopping power 87
B Havar® 89
Index iii
C Software and hardware used 91
C.1 Hardware . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
C.2 Geant4 simulation toolkit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
Geant4 performance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
C.3 Other software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
Bibliography 93
Acknowledgements 99
iv Index
List of Figures
1.1 Compound-nucleus reaction scheme . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.2 Definition of cross section . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.3 Scheme of a projectile fired towards a target . . . . . . . . . . . . . . . . . . . . 5
1.4 Plot of an excitation function . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.5 Graph of the approximated neutron energy spectrum of californium-252. . . . . 9
1.6 Scheme of a typical cyclotron’s double window system . . . . . . . . . . . . . . 11
2.1 Nuclear reaction of boron-10 irradiated by thermal neutrons (with 94% probability) 13
2.2 Cross section of the boron-10 (n,) reaction . . . . . . . . . . . . . . . . . . . . 15
2.3 An example of a BNCT treatment outcome in a 39-year-old man with histolog-
ically confirmed glioblastoma multiforme . . . . . . . . . . . . . . . . . . . . . . 17
2.4 BPA-fructose concentration model in blood . . . . . . . . . . . . . . . . . . . . 17
2.5 Scheme of a gamma-detection system with an anti-Compton shield . . . . . . . 18
2.6 High-Purity Germanium gamma spectra with and without anti-Compton sup-
pression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
2.7 BPA, BSH and some low molecular weight BNCT agents under investigation . 19
2.8 Typical PET images of fluorine-18-labeled-BPA in patients with GBM . . . . . 20
2.9 Gamma-ray spectrum of 158Gd . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.10 Comparison of flux-depth distributions for thermal and epithermal neutrons . . 22
2.11 Normal tissue depth-dose curves in a phantom for epithermal neutrons . . . . . 24
2.12 Clinical appearance of a case in a clinical trial . . . . . . . . . . . . . . . . . . . 26
2.13 X-ray and neutron cross sections for different elements . . . . . . . . . . . . . . 28
2.14 Comparison of neutron and X-ray images . . . . . . . . . . . . . . . . . . . . . 28
2.15 Radiograph of a computer floppy disk using neutrons and X-rays . . . . . . . . 28
2.16 Comparison and combination of X-ray and neutron images . . . . . . . . . . . . 29
2.17 Illustration of a typical neutron imaging system . . . . . . . . . . . . . . . . . . 29
2.18 Divergent collimator of a neutron imaging system . . . . . . . . . . . . . . . . . 30
2.19 Neutron imaging system with a CCD as optical system . . . . . . . . . . . . . . 32
2.20 Storage phosphors detector for neutron imaging . . . . . . . . . . . . . . . . . . 32
2.21 Gas detector principle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.22 Three-dimensional reconstructions of parts of a fuel injector device . . . . . . . 33
2.23 Neutron imaging applied to homeland security . . . . . . . . . . . . . . . . . . . 34
2.24 Another example of neutron imaging applied to homeland security . . . . . . . 34
2.25 A Roman sword inspected with X-rays and thermal neutrons . . . . . . . . . . 35
2.26 Nuclear processes involved in prompt gamma-ray neutron activation analysis
and neutron activation analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
2.27 Example of prompt gamma-ray neutron activation analysis spectrum from an
estuarine sediment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.1 Setup used for Geant4 (p,n) reactions validation . . . . . . . . . . . . . . . . . . 40
v
vi List of Figures
3.2 Comparison of experimental and simulated double differential cross sections for
the 9Be(p,n)9B reaction (0° <  < 5°) . . . . . . . . . . . . . . . . . . . . . . . 41
3.3 Comparison of experimental and simulated double differential cross sections for
the 9Be(p,n)9B reaction (15° <  < 25°) . . . . . . . . . . . . . . . . . . . . . . 42
3.4 Comparison of experimental and simulated double differential cross sections for
the 9Be(p,n)9B reaction (35° <  < 45°) . . . . . . . . . . . . . . . . . . . . . . 42
3.5 Comparison of experimental and simulated double differential cross sections for
the 9Be(p,n)9B reaction (55° <  < 65°) . . . . . . . . . . . . . . . . . . . . . . 43
3.6 Comparison of experimental and simulated double differential cross sections for
the 9Be(p,n)9B reaction (75° <  < 85°) . . . . . . . . . . . . . . . . . . . . . . 43
3.7 Comparison of experimental and simulated double differential cross sections for
the 9Be(p,n)9B reaction (95° <  < 105°) . . . . . . . . . . . . . . . . . . . . . 44
3.8 Comparison of experimental and simulated double differential cross sections for
the 9Be(p,n)9B reaction (115° <  < 125°) . . . . . . . . . . . . . . . . . . . . . 44
3.9 Comparison of experimental and simulated double differential cross sections for
the 9Be(p,n)9B reaction (140° <  < 150°) . . . . . . . . . . . . . . . . . . . . . 45
3.10 Comparison of experimental and simulated double differential cross sections for
the 9Be(p,n)9B reaction (165° <  < 175°) . . . . . . . . . . . . . . . . . . . . . 45
3.11 Comparison between experimental and (corrected) simulated double differential
cross sections for the 9Be(p,n)9B reaction (0° <  < 5°) . . . . . . . . . . . . . 47
3.12 Comparison between experimental and (corrected) simulated double differential
cross sections for the 9Be(p,n)9B reaction (15° <  < 25°) . . . . . . . . . . . . 47
3.13 Comparison between experimental and (corrected) simulated double differential
cross sections for the 9Be(p,n)9B reaction (35° <  < 45°) . . . . . . . . . . . . 48
3.14 Comparison between experimental and (corrected) simulated double differential
cross sections for the 9Be(p,n)9B reaction (55° <  < 65°) . . . . . . . . . . . . 48
3.15 Comparison between experimental and (corrected) simulated double differential
cross sections for the 9Be(p,n)9B reaction (75° <  < 85°) . . . . . . . . . . . . 49
3.16 Comparison between experimental and (corrected) simulated double differential
cross sections for the 9Be(p,n)9B reaction (95° <  < 105°) . . . . . . . . . . . . 49
3.17 Comparison between experimental and (corrected) simulated double differential
cross sections for the 9Be(p,n)9B reaction (115° <  < 125°) . . . . . . . . . . . 50
3.18 Comparison between experimental and (corrected) simulated double differential
cross sections for the 9Be(p,n)9B reaction (140° <  < 150°) . . . . . . . . . . . 50
3.19 Comparison between experimental and (corrected) simulated double differential
cross sections for the 9Be(p,n)9B reaction (165° <  < 175°) . . . . . . . . . . . 51
3.20 Comparison of experimental and simulated double differential cross sections for
the 9Be(d,n)10B reaction (0° <  < 8.28°) . . . . . . . . . . . . . . . . . . . . . 52
3.21 Setup used for Geant4 californium-252 decay mode verification . . . . . . . . . 53
3.22 Californium-252 energy modelization verification . . . . . . . . . . . . . . . . . 54
3.23 Verification of the isotropic emission of a Californium-252 source . . . . . . . . 55
4.1 Cyclotron beam energy and dispersion for protons . . . . . . . . . . . . . . . . 58
4.2 Cyclotron beam energy and dispersion for deuterons . . . . . . . . . . . . . . . 59
4.3 Thick target thickness optimization for the 9Be(p,n)9B reaction with yield 60°and
yield 89° . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
4.4 Thick target thickness optimization for the 9Be(p,n)9B reaction with total yield 60
4.5 Thick target thickness optimization for the 9Be(d,n)9B reaction with yield 60°and
yield 89° . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
4.6 Thick target thickness optimization for the 9Be(d,n)9B reaction with total yield 62
List of Figures vii
4.7 Scheme of setup type 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
4.8 Scheme of setup type 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
4.9 Simulation with a setup type 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
4.10 Simulation with a setup type 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
4.11 Energy spectrum of both neutrons and gammas with setup 1 . . . . . . . . . . 68
4.12 Energy spectrum of both neutrons and gammas with setup 2 . . . . . . . . . . 69
4.13 Energy spectrum of both neutrons and gammas with setup 3 . . . . . . . . . . 70
4.14 Energy spectrum of both neutrons and gammas with setup 4 . . . . . . . . . . 71
4.15 Energy spectrum of both neutrons and gammas with setup 5 . . . . . . . . . . 72
4.16 Energy spectrum of both neutrons and gammas with setup 6 . . . . . . . . . . 73
4.17 Energy spectrum of both neutrons and gammas with setup 7 . . . . . . . . . . 74
4.18 Scheme of the setup used for californium-252 simulations . . . . . . . . . . . . . 75
4.19 Simulation of the setup with californium-252 . . . . . . . . . . . . . . . . . . . . 76
4.20 Energy spectrum of both neutrons and gammas for the simulation with californium-
252 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
viii List of Figures
List of Tables
2.1 Thermal neutron capture cross sections . . . . . . . . . . . . . . . . . . . . . . . 14
2.2 Thermal neutron capture cross sections of the elements commonly present in
mammalian tissues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.3 Comparison between features of BSH and BPA . . . . . . . . . . . . . . . . . . 16
2.4 Gadolinium nucleus uptake determined for four GdNCT agents . . . . . . . . . 20
2.5 Typical values of efficiency for some common neutron detectors . . . . . . . . . 31
3.1 Proton stopping power and density of the target used . . . . . . . . . . . . . . . 40
3.2 Quantities related to proton energy and target thickness . . . . . . . . . . . . . 40
3.3 Deuteron energy and target thickness for (d,n) reaction validation . . . . . . . . 51
3.4 Parameters given by the Gaussian fit of californium-252 energy spectrum . . . . 53
3.5 Californium-252 equivalent time-mass with the number of neutrons simulated . 53
4.1 Thicknesses and densities of the materials used in the simulation . . . . . . . . 57
4.2 Resulting parameters of the Gaussian fits depicted in figure 4.1 . . . . . . . . . 58
4.3 Resulting parameters of the Gaussian fits depicted in figure 4.2 . . . . . . . . . 59
4.4 Optimal target thicknesses for the 9Be(p,n)9B reaction given by the grade 3
polynomial fit parameters. These fits are depicted in figures 4.3 and 4.4 . . . . 61
4.5 Optimal target thicknesses for the 9Be(d,n)9B reaction given by the grade 3
polynomial fit parameters. These fits are depicted in figures 4.5 and 4.6 . . . . 62
4.6 Densities of the materials used in the simulated setups . . . . . . . . . . . . . . 63
4.7 Characteristics of the setups simulated for (p,n) and (d,n) reactions . . . . . . . 64
4.8 Materials and their thicknesses used for gammas filter, thermal neutrons filter,
and shield of collimator exit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
4.9 Epithermal, fast, and thermal neutrons density flux, and gamma density flux
obtained with all (p,n) and (d,n) simulations . . . . . . . . . . . . . . . . . . . 67
4.10 Characteristics of the setup simulated with californium-252 . . . . . . . . . . . 75
4.11 Epithermal, fast, and thermal neutrons density flux, and gamma density flux
obtained with the californium-252 setup (figure 4.18) . . . . . . . . . . . . . . . 77
4.12 Estimated cost for a californium-252 source . . . . . . . . . . . . . . . . . . . . 79
A.1 Variables and values of the Bethe-Bloch equation. . . . . . . . . . . . . . . . . . 87
B.1 Nominal composition of Havar® . . . . . . . . . . . . . . . . . . . . . . . . . . 89
B.2 Physical properties of Havar® . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
C.1 Machines used to perform the simulations . . . . . . . . . . . . . . . . . . . . . 91
C.2 Geant4 performance measured in machine 1 with different setups and reactions 92
ix
x List of Tables
List of Acronyms and Abbreviations
BNCT Boron Neutron Capture Therapy
CCD Charge-Coupled Device
CF Compound Factor
DNA Deoxyribonucleic Acid
GBM Glioblastoma Multiforme
GdNCT Gadolinium Neutron Capture Therapy
IAEA International Atomic Energy Agency
ICNAS Instituto de Ciências Nucleares Aplicadas à Saúde, Coimbra, Portugal
LET Linear Energy Transfer
MRI Magnetic Ressonance Imaging
NAA Neutron Activation Analysis
NCT Neutron Capture Therapy
PLD Potentially Lethal Damage
RBE Relative Biological Effectiveness
SLD Sublethal Damage
xi
xii List of Acronyms and Abbreviations
Visão global
Sumário
Têm sido instalados um pouco por todo o mundo ciclotrões capazes de acelerar protões até 20
MeV, principalmente para produção de radioisótopos para tomografia por emissão de positrões.
No entanto, muitos desses ciclotrões estão equipados com várias linhas de feixe que podem ser
usadas para outros fins, nomeadamente investigação científica. Cada linha de feixe consegue
ter tipicamente uma corrente de protões até 150 A (1015 partículas/s). Neste trabalho é
estudada a viabilidade de implementar um sistema experimental de produção de neutrões
numa das linhas de feixe do ciclotrão de protões recentemente instalado na Universidade de
Coimbra, Portugal. Cada linha de feixe consegue entregar protões com energia de 18 MeV.
Uma implementação deste tipo poderia permitir estudos de radiobiologia (incluindo BNCT -
terapia de captura de neutrões com boro, boron neutron capture therapy, em inglês). Outras
utilizações incluem terapia de neutrões rápidos, investigação de materiais, imagem biomédica,
segurança interna e investigação fundamental em física, entre outras.
Objectivos desta dissertação
Este estudo é essencialmente um estudo de viabilidade, um estudo de pré-implementação. Nele
tentam dar-se respostas e soluções para uma eventual instalação de um sistema de produção
de neutrões. Todo este estudo foi feito com o auxílio de ferramentas de simulação de Monte
Carlo e várias opções foram exploradas.
Esboço deste trabalho
O primeiro capítulo é uma introdução aos conceitos físicos do trabalho. Não se pretende que
este capítulo seja muito exaustivo, muito pelo contrário: é uma forma de delinear as bases
físicas necessárias para compreender o trabalho, tanto para quem lê como para quem escreve.
O capítulo começa com um sumário do processo de fragmentação (spallation process, em in-
glês) e as reacções nucleares que lhe estão associadas nas energias relevantes deste trabalho.
Seguidamente são descritas algumas das características relacionadas com neutrões no que con-
cerne às suas interacções com a matéria, energias e fontes. O capítulo termina com a descrição
das características do ciclotrão instalado na Universidade de Coimbra no Instituto de Ciências
Nucleares Aplicadas à Saúde (ICNAS).
No capítulo 2 são revistas algumas das possíveis aplicações que um feixe de neutrões poderá
ter. Este capítulo inicia com a apresentação da terapia de captura de neutrões com boro,
passando pela imagem com neutrões e terminando na análise por activação com neutrões
(neutron activation analysis, em inglês). Neste capítulo o enfoque está no BNCT pois foi a
pensar nessa aplicação que este estudo se iniciou. No entanto, rapidamente se verificou que
xiii
xiv Visão global
várias outras aplicações seriam possíveis e portanto duas delas são incluídas também.
Como foram usadas ferramentas de simulação genéricas, não criadas para os objectivos deste
trabalho, é prudente recorrer a validações que permitam inferir se as simulações serão fiáveis.
Este trabalho de validação é descrito no capítulo 3.
No capítulo 4 encontra-se o estudo, por simulação, das possibilidades para implementar o feixe
de neutrões e as características que se podem esperar desse mesmo feixe.
Por fim, as conclusões desta dissertação e sugestões para trabalho futuro são apresentadas no
capítulo 5.
Overview
Summary
Cyclotrons capable of accelerating protons up to 20 MeV have been worldwide installed, mainly
for positron emission tomography radioisotope production. Nevertheless, most of these cy-
clotrons are equipped with several beamlines which may be used for other purposes, namely
scientific research. Each beamline may typically deliver proton currents up to 150 A (1015
particles/s). Here it is study the viability of implementing an experimental setup dedicated to
neutron production at one of the beamlines of the 18-MeV proton cyclotron recently installed at
the University of Coimbra, Portugal. Such implementation of a neutron beamline should allow
radiobiological studies (including BNCT - boron neutron capture therapy) to be performed.
Possible fall out applications comprise, besides neutron-based radiobiology, fields such as fast
neutron therapy, materials research, biomedical imaging, homeland security, and fundamental
research in physics, among others.
Objectives of this dissertation
This study is essentially a feasibility study. Here we try to give answers and solutions for an
eventual implementation of a neutron beamline. The entire study was made with Monte Carlo
simulation tools and several options were explored.
Outline
The first chapter is an introduction to the physical concepts needed for this work. It is not
intended to be a very thorough chapter, quite the contrary: it is a way to delineate the physical
basis necessary to understand this work, both for those who read and write. The chapter begins
with a summary of the spallation process and the nuclear reactions related to it, and with the
energies relevant for this work. Some of the characteristics associated with neutrons such as
their interactions with matter, energy ranges, and sources are presented after. The chapter
ends with a description of the cyclotron installed at the University of Coimbra in Instituto de
Ciências Nucleares Aplicadas à Saúde (ICNAS).
In chapter 2 a review is made about some possible applications that a neutron beam may have.
This chapter begins with the presentation of boron neutron capture therapy (BNCT) and then
neutron imaging and neutron activation analysis are also focused. In this chapter BNCT is
more discussed because it was the trigger of this study. However, it was realized soon that
several other applications are possible and therefore two of them are also included.
Since generic simulation tools were used, it is prudent to use validations that should infer if
the simulations are reliable. This validation work is described in chapter 3.
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In Chapter 4 the simulation study is presented together with some of the possibilities to im-
plement the neutron beam and the characteristics that might be expected of such beam.
The conclusions from this dissertation, together with future work suggestions, are presented in
chapter 5.
Part I
Introduction
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Chapter 1
Physics Background
1.1 Spallation process
The word spallation comes from spall and it means small pieces of material that are ejected
from a target after some sort of projectile collides with it. There is no general definition
of the term ’spallation reaction’, nevertheless this type of reaction is observed in astrophysics,
geophysics, radiotherapy, radiobiology, and at all applications together with accelerators [Fil09].
But for all practical purposes, spallation refers to nonelastic nuclear reactions that occur when
energetic particles interact with an atomic nucleus. These particles can be protons, neutrons
or pions [Fil09]. Although one possible definition refers to a minimum energy of the incident
particles around tens of MeV, there is no clear separation of spallation from the lower energy
nuclear reactions [Fil09]. A definition for spallation to be specified in the context of accelerator
driven systems or high-intensity neutron sources is the disintegration of a nucleus by means
of high energetic proton-induced reactions [Fil09]. Assuming that the projectile has sufficient
energy to break the Coulomb barrier, two main nuclear reactions can occur, compound-nucleus
reaction and/or direct reaction.
1.1.1 Compound-nucleus reaction
This kind of reaction assumes the formation of an intermediate state before the release of the
outgoing particles. Admitting that the projectile has sufficient energy to overcome the Coulomb
barrier, this reaction begins when the projectile enters the target nucleus and interacts with one
of the nucleons. After this first step, the less energetic projectile and the recoiling nucleon will
have successive collisions and the process carries on until there is no excess energy available. In
this intermediate state a combined system between projectile and nucleus is created (compound-
nucleus). Although the average energy gain per nucleon is small and not enough for ejection to
occur, statistically some (few) nucleons may exist with sufficient energy to escape the nucleus
(Figure 1.1) [Kra88].
1.1.2 Direct reaction
Direct reactions are those in which the interaction occurs primarily with only one nucleon
and at the surface of the target nucleus, so they are also known as peripheral reactions. The
probability of this type of reaction increases with increasing projectile energy (or with the
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Figure 1.1: Compound-nucleus reaction scheme. Up to 10 16 s the outgoing particles are nucle-
ons, and after, if emission occurs, gammas are produced [Kra88]. Image for illustrative purposes
only without considering all possibilities.
decrease of the projectile wavelength according to the de Broglie relation - the smaller the
wavelength, the higher the probability of the projectile ’to see’ the nucleons and interact with
them [Kra88]. It should be noticed that another type of direct reaction exists, the central
reactions. These reactions are only seen for higher energies1 and they are characterized by the
complete fragmentation of the target nucleus [Pau05].
1.2 Reaction probability
Considering a general case of incoming particles of type A incident on a target of type B with
the reaction [Roh94]:
A + B ! FINAL STATE (1.1)
The final state can be any possible outcome. The rate at which one given final state is produced
is called transition rate. The probability for A + B to produce a certain final state or group of
final states is specified by the interaction cross section, , which is defined to be [Roh94]:
 =
transition rate : A + B ! FINAL STATE

=
R

(1.2)
Here  is the incident flux of the particles of type A, defined by the number of projectiles
of type A (N) per covered area in target B (a) and per unit of time (t) and with R as
transition rate [Roh94]:
 =
N
at
=
Ri
a
(1.3)
1 Compared with the energies available for this work.
1.2. Reaction probability 5
With N=t as Ri (rate of incident particles in the target).
Figure 1.2: Definition of cross section in the particular case of scattering. However this example
can be extrapolated to other cases. After [Roh94]
Figure 1.3: Scheme of a projectile fired towards a target of thickness L.
Now looking at the example depicted in figure 1.3, the number of nuclei per area of target
(Nnucleus=a) is given by [Roh94]:
Nnucleus
a
=
NAL
M
(1.4)
Where NA is Avogadro’s number,  is the density, and M is the molar mass.
Since each incident particle has a chance to interact with the target nuclei along the thickness
of the target, it is useful to calculate the cross section per target nucleus. Therefore, the
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corresponding incident flux should be [Roh94]:
 =
RiNnucleus
a
=
RiNAL
M
(1.5)
Given that the cross section is expressed by the transition rate divided by the incident flux,
the cross section per target nucleus is [Roh94]:
 =
R

=
R
RiNAL
M
 = R
Ri
M
NAL
(1.6)
Cross section has units of area. The unit of cross section, barn (b), is defined to be 10 28 m2.
In several situations it is useful to express cross section as a function of energy, (E), sometimes
called excitation function (figure 1.4). With this function it is possible to choose the most
favorable energy for a given reaction [Alv08].
Figure 1.4: Plot of an excitation function. Adapted from [Tak03]
1.2.1 Thick target yields
Thick target yield is an important practical quantity to express the final state yield (about
final state, refer to the section 1.2) for one such target. The expected thick target yield (Y ) is
given by [Alv08]:
Y =
NAH
Mzqe
Z Eout
Ein

dE
dx
 1
(E)dE (1.7)
Where NA is the Avogadro’s number,M andH are the atomic mass and the isotopic abundance
of the target, respectively, z is the atomic number of the projectile, and qe is the electron
charge. The remaining part of the expression contains the integration of the inverse stopping
1.3. Neutrons 7
power1 times the excitation function between the energy of the incoming particle (Ein) and its
energy upon crossing the target (Eout) [Alv08].
1.3 Neutrons
Neutron was observed for the first time by Bothe and Becker when they were bombarding a
beryllium target with alpha particles. The emerging particles were first mistaken with highly
energetic gammas but, soon after, Curie and Joliot realized that if those particles were gammas
they should have at least 52 MeV, an unlikely scenario. It was Chadwick who proposed an
explanation for those particles with the hypothesis of being neutral and, therefore, rather
penetrating [Kra88].
1.3.1 Neutron-matter interactions
Since neutrons are neutral, the reactions that they can undergo are different from those induced
by charged particles. An example of this is the fact that, being neutral, neutrons do not ionize
directly [Kra88] and can enter the nucleus without feeling the Coulomb barrier. However,
neutrons can ionize indirectly because they can produce high energetic particles capable of
ionizing [Alp98]. According to Reuss, the neutron-induced reactions can be [Reu08]:
 Scattering : any reaction with at least one neutron in the final state
 Absorption: any reaction that terminates the neutron travel in a free state
 Fission (induced): the absorption leads to the fission of the compound-nucleus formed
 Capture: any other type of absorption
Scattering reactions can be divided in two main types: elastic and inelastic. In elastic scattering
processes, a neutron collides with a nucleus, transfers some energy to it and, consequently, is
deviated from its initial direction of motion. Conversely, in the process of inelastic scattering
the incident neutron goes into the nucleus and a compound-nucleus is formed. Then, the
neutron is re-emitted with lower kinetic energy and the nucleus is left in an excited state. The
return to the ground state is accompanied by the emission of gamma rays [Pod06]. Neutron
capture is similar to inelastic scattering but without the re-emission of the neutron, other
particle being in general emitted [Alp98]. By convention, this reaction happens at low energies
(i. e., around thermal energy - section 1.3.2). When this reaction is seen at higher energies, it
is called nonelastic scatter [Alp98].
When the goal is to reduce the neutron kinetic energy, low atomic mass materials should be
used [Lev01] because of the higher probability (cross section) for elastic scattering. This process
of slowing down the neutrons, called moderation, is ruled by equation 1.8, where (4Ek)max is
the maximum possible energy transfer to the target nucleus, mn is the neutron mass, and M
is the target nucleus mass [Pod06].
(4Ek)max = Eki
4mnM
(mn +M)2
(1.8)
1 See appendix A
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With equation 1.8 it is easy to understand why low atomic mass materials are preferred: the
lower the atomic mass, the higher can be the maximum energy transfer and, therefore, a more
effective moderation can be achieved.
Besides of moderators one should mention reflectors, materials which, as the name implies,
can reflect neutrons back to the desirable track. In these materials, neutrons should not lose
much energy and so, reflector materials must have a high elastic scattering cross section and,
according to the equation 1.8, a high atomic mass to minimize energy transfer [Lev01, Pod06].
Examples of these materials are Pb, Bi and PbF2 [Lev01].
1.3.2 Neutron energy ranges
By convention, several designations are given to neutrons according to their energies. Unfor-
tunately, there is no agreement within the scientific community pertaining to this convention,
as can be seen in several publications such as [Kra88, Pod06, Reu08, And09, Lev01]. The
exception for this is the energy of the so called thermal neutrons1.
Given the lack of a clear definition of such terms, the designations used in this work are:
 Cold neutrons: energies bellow 0.025 eV
 Thermal neutrons: energies around 0.025 eV
 Epithermal neutrons : energies between 0.5 eV and 10 keV
 Fast neutrons: energies above 10 keV
1.3.3 Neutron sources
Neutrons do not have charge so they cannot be accelerated as charged particles are. The only
solution to tune the energy of a neutron beam is to produce it through nuclear reactions and
then moderate the beam if its energy is too high for the envisaged purpose [Kra88]. According
to Krane, there are five main neutron sources, alpha-beryllium sources, photo-neutron sources,
spontaneous fission, nuclear reactions, and reactor sources [Kra88]. They can be summarized
as follow:
 Alpha-beryllium sources : they make use of the reaction 4He + 9Be ! 12C + n. The
alpha-emitting material can be, for example, 226Ra and with this solution it is possible
to have a constant rate of neutron production [Kra88].
 Photo-neutron sources : its principle is similar to the alpha-beryllium sources, but use
gammas instead of alphas and the reaction is  + 9Be ! 8Be + n. Sodium-24 and
antimony-124 can be used as gamma source [Kra88].
 Spontaneous fission: the source that is widely used with this kind of nuclear reaction is
californium-252.
1 The expression thermal neutrons comes from the fact that those neutrons have a characteristic room temper-
ature (300 K) energy, 25.85 meV [And09]. This measure leads to the agreement about the thermal neutron
energy.
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 Nuclear reactions : nuclear reactions are those associated with the spallation process
(section 1.1).
 Reactor sources : near the core of a nuclear fission reactor the neutron flux can be very
high (typically 1014 neutrons/cm2/s), therefore a neutron beam can be achieved with a
small hole in the reactor’s shield [Kra88].
Californium-252
There are about 100 radionuclides that decay by spontaneous fission with neutron emis-
sion [Kar97]. Despite this high number of neutron emitting radionuclides, californium-252
has been the choice for the vast majority of applications that require a small and/or portable
neutron source. Reasons such as inadequate half-life (too short or too long), rareness, and
production difficulties are the main motives to overlook the other radionuclides in favor of
californium-252 [Kar97]. Californium-252 decays by alpha emission (96.91%) and spontaneous
fission (3.09%), which gives a half-life of 2.645 years with a neutron emission of 2:314 
106 s 1g 1 [Mar99]. The neutron energy spectrum was measure by Smith et al. and a
function was proposed to model this emission (equation 1.9), where N represents the relative
number of neutrons and E is the neutron energy in MeV [Smi57]. This equation was validated
for the energy range between 0.2 MeV and 7.0 MeV [Smi57].
N(E)  e 0:88E sinh[(2:0E) 12 ] (1.9)
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Figure 1.5: Graph of the equation 1.9 representing the approximated neutron energy spectrum
of californium-252.
For this emission spectrum, the most probable energy and the average energy are about 0.7
MeV and 2.1 MeV, respectively [Mar99], and are released 3:756  0:010 neutrons [Gol73] and
7:98  0:40 gammas [Val99] per fission, making this source suitable for many applications.
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For example, at the Californium User Facility for Neutron Science in Oak Ridge National
Laboratory, californium-252 has been used for such different situations as land mine detection
system, neutron damage testing solid-state detectors, irradiation of human cancer cells (BNCT
experiments), and irradiation of rice to induce genetic mutations [Mar99].
1.4 ICNAS cyclotron
The cyclotron present at ICNAS is an IBA Cyclone® 18/9 HC capable of accelerating protons
(18 MeV) and deuterons (9 MeV). The announced beam currents are 150 A and 40 A
for protons and deuterons, respectively. Besides of this ’commercial’ informations, through a
contact with IBA Molecular some more details were obtained.
1.4.1 Energy
Cyclotron accelerates protons up to 18.5 MeV, but the particles lose about 1 MeV when they
interact with the materials at the port of the cyclotron (figure 1.6). At ICNAS, the materials
used on the beam port are [Alv10a]:
 Havar®1: to maintain the necessary low operating pressure inside the cyclotron
 Gaseous helium: to act as a cooling system
 Aluminum or titanium: to separate the gaseous helium from the exterior of cyclotron,
support the sample and act as a thermal bridge between the helium and the sample
Therefore, it is possible to have an external proton beam with about 17.5  0.2 MeV (uncer-
tainty given by [Alv10b]). With deuterons, the loss in the port materials is about the same
and since the accelerated beam reaches 9.2 MeV, it is possible to have an external deuteron
beam of about 8.2  0.1 MeV (after [Alv10b]).
1.4.2 Beam density and dispersion
Beam density for protons and deuterons is approximately Gaussian with 80% and 70% in-
side 10 mm at 30 cm after cyclotron port and the remain 20% and 30% within 3, respec-
tively [Alv10b]. The beam profile was measured by Tamburella and Giles and its Gaussian
shape was confirmed [Tam08].
The dispersion of the beam is mainly the result of its interaction with Havar® [Alv10b] and
so in section 4.1 a simulation study of a pencil beam passing through a foil of this material is
presented.
1 See appendix B.
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Figure 1.6: Scheme of a typical cyclotron’s double-window system. The materials and their
thicknesses depicted in the picture are specific for the IBA Cyclone® 18/9 HC present at ICNAS.
After [Alv10a]
.
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Chapter 2
Neutron Applications
The field of neutron applications is vast. This study aims at radiobiological studies, but
many more uses can be found for neutrons: materials research, biomedical imaging, homeland
security, and fundamental research in physics, among others.
2.1 Neutron capture therapy
2.1.1 Principles
Neutron capture therapy (NCT) was proposed by Locher in 1936 [Sal04, Lev01] after Goldhaber
had discovered that boron-10 captures thermal neutrons and then disintegrates into an energetic
alpha particle back to back with a recoiling lithium-7 ion [Lev01]. The lithium-7 nucleus and
the alpha particle have a combined track length in soft tissues of about 14 m [Ryy02], therefore
within cell dimensions [Chu99], and both are high linear energy transfer (LET) particles causing
sublethal and potentially lethal damage to DNA [Bar92]. In theory, boron neutron capture
therapy (BNCT) provides a way to selectively destroy malignant cells and spare normal cells
if a sufficient amount of boron-10 is delivered to the tumor beforehand [Bar05].
Figure 2.1: Nuclear reaction of boron-10 irradiated by thermal neutrons (with 94% probability).
After [Lev01].
First tumors to be treated with BNCT were brain tumors, particularly glioblastoma multiforme
(GBM) [Lev01], which is one of the most malignant and therapy resistant tumors known.
GBM is usually fatal because of regrowth or resistance of the primary tumor. It is rare to
13
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see metastases from GBM, although its growth pattern can lead to the involvement of regions
of the brain at some distance from the primary tumor [Gup03]. Meanwhile, since the initial
clinical trials, BNCT was also used to treat other types of brain tumors [Nak03], primaries
or cerebral metastases of melanomas [Bar03, Bar05], head and neck tumors [Bar05], and liver
tumors [Bar05]. For some cases the results seem to be equivalent to and, for others, the results
surpass conventional radiotherapy (survival rate and survival time). There is some ambiguity
among the published results which is due to the complexity of BNCT. BNCT is currently
undergoing Phase I and Phase I/II clinical trials [Gup03].
2.1.2 Compounds for NCT
Boron has been the main element used in NCT since the initial proposal by Locher. Other
nuclides also have high capture cross section for thermal neutrons, sometimes even higher than
boron-10 (tables 2.1 and 2.2) [Sol97], but boron-10 has three great advantages:
1. High capture cross section for thermal neutrons (tables 2.1 and 2.2) with emission of high
LET particles limited to a very short track length (equations 2.1 and 2.2) [Sol97, Lev01]
2. Boron compounds rival carbon in their extensive covalent chemistry and stability, allowing
for the synthesis of many, very different chemical entities [Sol97]
3. Boron-10 is not a radioactive isotope and it is non-toxic [Sal04]
n + 10B ! 11B ! 4He (1:78 MeV ) + 7Li (1:01 MeV ) [4%] (2.1)
n + 10B ! 11B ! 4He (1:47 MeV ) + 7Li (0:84 MeV ) +  (0:478 MeV ) [96%] (2.2)
Table 2.1: Thermal neutron capture cross sections (th) for selected stable isotopes. Adapted
from [Sal04].
Isotope th (barn) Neutron capture reaction
3H 5333 (n,p)
6Li 941 (n,)
10B 3838 (n,)
113Cd 20600 (n, )
147Sm 40140 (n, )
151Eu 9200 (n, )
155Gd 60900 (n, )
157Gd 255000 (n, )
199Hg 2150 (n, )
Besides the advantages of boron-10, gadolinium-157 has been studied as a NCT agent, alone
or mixed with boron-10 [Cul04]. Gadolinium-155 and gadolinium-157 are isotopes of interest
for NCT due to both their high capture cross section for thermal neutrons and the products
of that capture reaction. Moreover, the latter isotope has the highest thermal neutron capture
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Figure 2.2: Cross section of the boron-10 (n,) reaction. It is possible to visualize the general
1
v
behaviour of the capture cross sections for neutrons at low energies, where v is the velocity of
the neutron. After [Reu08].
Table 2.2: Thermal neutron capture cross sections (th) of the elements commonly present in
mammalian tissues. Adapted from [Sal04].
Isotope th (barn) Weight % in mammalian tissues
1H 0.333 10.0
12C 0.0035 18.0
14N 1.83 3.0
16O 0.00019 65.0
23Na 0.43 0.11
24Mg 0.0053 0.04
31P 0.18 1.16
32S 0.53 0.20
35Cl 32.68 0.16
39K 2.1 0.20
40Ca 0.4 2.01
56Fe 2.57 0.01
cross section of all stable nuclides in the periodic table [Sal04]. The reaction 157Gd(n,)158Gd
generates prompt gamma emission up to 7.8 MeV [Sta01], with average energy around 2.2 MeV
and a path length of several centimeters in live tissue [Sal04]. In this reaction other particles
are produced, but the most biologically relevant are the five Auger electrons emitted in each
neutron capture [Sta05, Sal04]. These low energy Auger electrons have a path length of only
several nanometers in aqueous solutions (5-40 nm) [Sal04]. Despite the absolute low energy, the
very short path length of these Auger electrons makes them high LET particles within a mean
free path length of 12.5 nm [Sal04] that may induce double-strand damage in DNA [Sta01].
Since this ionizing radiation is limited to molecular dimensions, for significant DNA damage
induction in tumor cells, it is essential to place the gadolinium atoms into the DNA helix or
as near as possible, i.e., within the nucleus [Sal04, Sta05]. Furthermore, gadolinium has two
other reasons to be a potentially good neutron capture therapy agent:
16 Chapter 2. Neutron Applications
1. Several gadolinium compounds are known to target brain gliomas, because of brain blood
barrier disruption in these tumors (they are in fact used as tumor contrast-enhancing
agents for magnetic resonance imaging (MRI)) [Sta01]
2. The search of gadolinium compounds to be used with MRI allowed for a wealth of in-
formation about pharmacokinetics, biodistribution, and tolerance of those compounds to
be assembled [Sta01]
3. Gadolinium compounds should allow MRI monitoring of the treatment [Sal04]
Boronated compounds
These compounds were the first to be applied to NCT and they are being developed for about
50 years now [Bar05]. The most important requirements for a successful boron delivery agent
are [Bar05]:
 Low systemic toxicity and normal tissue uptake with high tumor uptake and tumor/blood
concentration ratio higher than 3-4:1
 Tumor concentrations of boron-10 around 20 g per gram of tumor
 Rapid clearance from blood and normal tissues and persistence in tumor during treatment
However, until 2005 no single boron delivery agent achieved these criteria [Bar05] and un-
til 2009 the progress made was almost none [Bar09]. In the first BNCT clinical trials, boric
acid and some of its derivatives were used, but those simple chemical compounds were non-
selective and had poor tumor retention [Bar05]. In the 1960s, two other boron compounds
emerged, BPA1 (compound 1 in figure 2.7) and BSH2 (compound 2 in figure 2.7) [Bar05, Bar09].
These compounds had low toxicity, persisted longer in animal tumors compared with related
molecules, and had tumor/brain and tumor/blood boron ratios greater than 1 [Bar05, Sal04].
Boron-10-enriched BSH and BPA, complexed with fructose to improve its water solubility, have
been used clinically in Japan, the United States, Europe, and Argentina. Although these drugs
are not ideal, their safety following intravenous administration has been established [Bar05],
and pharmacokinetics models can predict tumor, blood, and normal tissue boron-10 concentra-
tions (figure 2.4) [Kig03, Kor04, Ryy02]. The new generation of BNCT delivery agents mainly
consists of a stable boron group attached via a hydrolytically stable linkage to a tumor-targeting
functional group, such as low molecular weight biomolecules or monoclonal antibodies [Bar05].
Table 2.3: Comparison between features of BSH and BPA important to BNCT. After [Chu99].
Compound Concentrations of Tumor/normal tissue Tumor/blood
boron-10 in tumor (ppm) ratio ratio
BSH 3-20 >10 1
BPA 15-45 and higher 2-4 3-5
One of the main concerns about BNCT is how to measure boron-10 concentrations in real-
time during treatment. The gammas emitted in 94% of the neutron captures are one option.
1 (L)-4-dihydroxy-borylphenylalanine
2 Sodium mercaptoundecahydro-closo-dodecaborate
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Figure 2.3: An example of a BNCT treatment outcome in a 39-year-old man with histologically
confirmed glioblastoma multiforme. Left panel: A MRI scan taken 10 days after brain surgery
showing an enhancing tumor. Middle panel: A MRI taken one month following BPA-based BNCT
suggesting tumor response. Right panel: A MRI three months following BNCT. After [Joe03].
Figure 2.4: BPA-fructose concentration model was achieved considering the dose and duration
as actually administered to each patient. Three simulated irradiation fields are delivered, with the
first starting 45 minutes after the end of infusion and with 30 minutes between fields. Only blood
samples taken up until 15 minutes before the start of each irradiation were used to determine the
model prediction of boron-10 concentration for each field, as indicated by the three horizontal bars
at the top. After [Kig03].
The work of Burlon et al. demonstrated that this is feasible with prompt gamma-ray analysis
(figures 2.5 and 2.6) [Bur05].
On the other side, measurements of the concentration of boron-10 in vitro and ex vivo can be
made with the same prompt gamma-ray analysis [Kig03], and with ICP-AES1 [Kor04, Kig03].
Studies in vivo can be done using a form of fluorine-18-labeled-BPA and a positron emission
1 Inductively coupled plasma atomic emission spectroscopy
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Figure 2.5: Scheme of a gamma-detection system with an anti-Compton shield. After [Bur05].
Figure 2.6: High-Purity Germanium gamma spectra with and without anti-Compton suppression
obtained with the setup of figure 2.5. After [Bur05].
tomography (PET) scan (figure 2.8) [Kig03, Kab97, Ima98].
Gadolinium compounds
Until 2001 gadolinium neutron capture (GdNCT) did not undergo clinical trials [Sta01], how-
ever, several studies have been made to test the benefits of this approach [Sta01, Sta05, Sal04,
Cul04]. Due to its availability and tumor-seeking properties [Sta01], standard gadolinium con-
trast agents for MRI have been explored to be used as GdNCT compounds as well [Sta01,
Sta05, Sal04]. Examples of these agents are Gd-DTPA1 and Gd-DOTA2 [Sal04, Sta05]. Two
1 Gadolinium-diethylene triamine pentaacetic acid
2 Gadolinium-tetraazacyclododecane tetraacetic acid
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Figure 2.7: BPA, BSH and some low molecular weight BNCT agents under investigation. BPA
(compound 1) and BSH (compound 2) are currently in clinical use. GB-10 (compound 3) has
shown promising results in animal models, as have the nucleoside derivatives -5-o-carboranyl-2´-
deoxyuridine (D-CDU; compound 4) and N5-2OH (compound 5). Compound 6, a trimethoxyin-
dole derivative, has shown promise in vitro and compound 7, H2DCP, a porphyrin derivative, was
shown to be tumor selective. The maltose derivative, compound 8, has shown low cytotoxicity
and tumor cell uptake in vitro, the biphosphonate, compound 9, has tumor-targeting ability, and
the dequalinium derivative dequalinium-B (DEQ-B; compound 10) has shown promise in in vitro
studies. After [Bar05].
other compounds have been developed, Gd-Tex1 as a radiosensitizer, and HDG as a DNA-
targeting contrast agent [Sal04]. Good results were already obtained for HDG for in vitro and
in vivo experiments (table 2.4) [Sal04].
Although the two main BNCT drugs, BPA and BSH, have different delivery mechanisms,
they share a common limitation: because the products of the (n,) reaction of boron-10 have
low path lengths, it is necessary to have boronated compounds inside every tumor cell, so an
1 Motexafin gadolinium
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Figure 2.8: Typical PET images of fluorine-18-labeled-BPA in patients with GBM. (A) MRI
image with gadolinium enhancement; (B) PET images corresponding to the MRI; (C) Dynamic
PET study. Adapted from [Ima98].
Table 2.4: Gadolinium nucleus uptake criteria (QGd) determined for four GdNCT agents on
TB10 GBM cell cultures. Adapted from [Sal04].
Contrast agent/radiation sensitizer QGd GBM cell nucleus uptake (% cells)
Gd-DTPA 0.2 2.5
Gd-DOTA 14 14
Gd-Tex 2.5 92
HDG 20 100
Note: QGd =
Gdintracelullar
Gdextracelullar
after 74h exposure.
uniform intercellular drug uptake is needed [Cul04]. Thus, despite the limitations of these
compounds, such uptake is also related to tumor vascularization and cell metabolism [Cul04].
This issue is relevant when there are quiescent tumor cells (less active or even dormant tumor
cells) that some studies found to have extremely limited uptake of BPA [Cul04]. This is related
to the very low metabolic rate of those cells and, although BSH is less dependent on this factor,
there are no studies that can confirm the uptake of BSH in all quiescent cells [Cul04]. Since
almost all products of the (n,) reaction of gadolinium-157 have longer ranges than those of the
boron-10 reaction, GdNCT can kill tumor cells without stringent requirements on uptake uni-
formity [Cul04]. Another significant advantage of gadolinium compounds over boronated ones
is the fact that the latter are retained in the lysosomes which are randomly distributed through-
out the cytoplasm and around the cell nucleus [Sta01]. No selective concentration into the cell
nucleus has yet been demonstrated for boronated compounds whereas the study of Stasio et
al. has demonstrated that gadolinium preferentially concentrates in the cell nucleus [Sta01].
Some studies have shown that GdNCT has more limitations than BNCT, mainly due to the
longer interaction lengths of the low-LET neutron capture products of gadolinium [Cul04].
GdNCT is less localized and, consequently, results in lower increase of tumor dose over the
healthy tissue dose and in a decreased therapeutic ratio [Cul04]. However, gadolinium com-
pounds can be combined with boronated compounds and some possible advantages can come
from this combined approach [Sal04, Tak05].
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Apart from MRI, there are some techniques to study the location of gadolinium in vitro and/or
in vivo. Due to the impossibility of detecting Gd-DOTA and Gd-DTPA by the conventional
approach (fluorescence microscopy and autoradiography), Stasio et al. used synchrotron spec-
tromicroscopy, ICP-MS1, ToF-SIMS2, and MEPHISTO3 spectromicroscopy [Sta05]. In the
study of Takahashi et al., they used prompt gamma-ray analysis and -autoradiography to
assess the biodistribution ex vivo of a mixture compound of BPA and Gd-DTPA [Tak05]. It is
also possible that real-time monitoring during treatment can be achieved with prompt gamma-
ray analysis knowing the gamma-ray spectrum (figure 2.9) and with a system similar to the
one shown in figure 2.5.
Figure 2.9: Gamma-ray spectrum of 158Gd. After [Whi73].
2.1.3 Neutron beamline requirements
For NCT, an adequate thermal neutron field has to be created in the boron-labeled tumor
cells within a prescribed target volume [Lev01]. This means that for target volumes well below
surface, epithermal beams will generally be best, while for target volumes near the surface,
thermal beams will suffice (figure 2.10) [Lev01].
Current experience with BPA and BSH shows that a desirable minimum beam intensity would
be 109 epithermal neutrons cm 2 s 1. Beams of 5 108 n cm 2 s 1 are usable, but result in
1 Inductively coupled plasma mass spectrometry
2 Time-of-flight secondary ion mass spectrometry
3 From the French, microscope à émission de photoélectrons par illumination synchrotronique de type onduleur
(photoelectron emission microscope by synchrotron undulator illumination)
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Figure 2.10: Comparison of flux-depth distributions for thermal and epithermal neutrons. Af-
ter [Lev01].
rather long irradiation times [Lev01]. When higher intensity beams are available the advantages
of shorter irradiation times must be weighted against those of improved beam quality1. Where
there is a choice to be made, most practitioners would rather have better quality rather than
more intensity, within the constraint of having a reasonable treatment time (possibly extending
up to one hour) [Lev01, Bar05]. It should be noticed that if the currently used values of boron
concentration can be raised, beam intensity requirement (or treatment time) will be reduced
proportionately and the values presented do not take fractionation into account [Lev01]. Beam
quality is determined by three main parameters and they are discussed below by order of
importance.
1. Fast neutron component: fast neutrons, which invariably accompany the incident
beam, have a number of undesirable characteristics such as the production of high LET
protons with a resulting energy dependence on their induced biological effects. There-
fore, it is one of the main objectives of BNCT beam design to reduce the fast neutron
component of the incident beam as much as possible [Lev01].
2. Gamma ray component: because of the energy range of the gamma radiation, it
results in a non-selective dose to both tumor tissue and a large volume of healthy tissue.
Hence, it is desirable to remove as much gamma radiation from the beam as possible.
Since there are also (n,) reactions occurring inside the patient, the importance of this
component in the incident beam is somewhat reduced [Lev01].
3. Ratio between thermal flux2 and epithermal flux: to reduce damage to the scalp,
1 With higher intensity beams it is possible to choose moderators for achieving better beam quality (i.e. better
energy distribution) without concerns about loosing beam intensity. In contrast, with lower intensity beams
the main concern is to reach neutron epithermal energies without significant reduction of beam intensity,
sometimes overlooking beam quality
2 The neutron flux is defined by the number of neutrons per unit of area per unit of time (neutrons cm 2 s 1)
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thermal neutrons in the incident beam should be minimized. A target number for the
ratio of thermal to epithermal flux should be 0.05 [Lev01].
The beam size is not defined and can change as needed. Circular apertures of 12 to 14 cm
diameter are being used in the present clinical trials. However, sizes of up to 17 cm have been
proposed for irradiation of brain tumors. Other cancers in the body might require even larger
apertures. These maximum sized apertures are reduced in accordance with the tumor size and
position as determined by the treatment planning requirements [Lev01].
Since an epithermal neutron beam is needed, one should use moderators to reduce neutrons
kinetic energy [Lev01, Bar05, Chu99, Gup03]. Any moderator materials chosen must not de-
compose in a high radiation field, nor produce moisture. Any neutron activation products
from the materials should be short lived. Suitable candidates are Al, C, S, Al2O3, AlF3,
D2O, and (CF2)n. Combinations of Al followed by Al2O3 or AlF3 downstream are very ef-
ficient because O and F cross sections fill in the valleys between the energy resonance peaks
of Al [Lev01, Mau98, Lud97]. Furthermore, a mixture of 60% Al and 40% AlF3 was pro-
posed [Lud97]. Fluental™ 1 was developed by the technical Research Centre of Finland and
stands up well to radiation, but is very expensive. Teflon™ is susceptible to radiation dam-
age, but even so, may be acceptable when exposed to the relatively modest neutron fluences
projected for the facility over its anticipated lifetime [Lev01].
2.1.4 Radiobiological considerations
Dose calculations
Given an incident radiation beam similar to those applied in BNCT, there are four dose com-
ponents when the beam enters the tissue (figure 2.11) [Lev01, Chu99]:
 The gamma dose: the dose due to gamma rays accompanying the neutron beam as well
as gamma rays induced in the tissue itself. In the latter case, hydrogen in tissue absorbs
thermal neutrons in 1H(n,gamma)2H reactions and emits 2.2 MeV gamma rays (table
2.2), to which tissue is quite transparent.
 The neutron dose or proton-recoil dose: epithermal and fast neutrons cause ’knock-on’ re-
coil protons from hydrogen in tissue in 1H(n,n’)1H reactions resulting in locally deposited
energy from recoiling protons.
 The nitrogen dose: nitrogen-14 in tissue absorbs a thermal neutron and emits a proton
in a 14N(n,p)14C reaction (table 2.2). Dose results from locally deposited energy from
the energetic proton and the recoiling 14C nucleus.
 The boron dose: boron-10 absorbs a thermal neutron in a 10B(n,)7Li reaction. The
energetic alpha particle emitted and the recoiling lithium-7 ion result in locally deposited
energy averaging about 2.33 MeV. In about 94% of events the recoiling lithium-7 ion is
produced in an excited state and de-excites in flight, emitting a 477 keV gamma ray.
In the remaining events, lithium-7 is emitted in the ground state with no gamma ray
emission. Because the emitted gamma rays from boron-10 neutron capture are about
two orders of magnitude less prevalent and about one-quarter the energy of the 2.2 MeV
1 Fluental™ is a patented material with AlF3 (69%-weight), aluminum (30%-weight) and LiF (1%-
weight) [Lev01]
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gamma rays from hydrogen capture, they can be ignored from a dosimetric perspective,
although they are frequently utilized for boron-10 analysis purposes (figures 2.5 and 2.6).
Figure 2.11: Normal tissue depth-dose curves in a phantom for epithermal neutrons. Af-
ter [Chu99].
Neutrons not captured by boron-10 nuclei produce unwanted background radiation through
a number of reactions with nuclei in normal tissue, such as nitrogen, hydrogen, carbon, and
chlorine [Lev01, Chu99]. Additionally, there are contaminations in the neutron beam, such as
gamma rays or fast neutron components not filtered out from the beam. These background
radiations contribute equally to the dose in normal tissue and tumor volumes independent of
boron-10 concentration [Chu99]. However, a higher concentration of boron-10 in the tumor will
result in it receiving a higher total dose than that of adjacent normal tissues [Bar05, Chu99,
Lev01, Bar92]. This is the basis for the therapeutic gain in BNCT [Bar05].
Therapy planning of BNCT using epithermal neutron beams requires calculation of the bio-
logical dose distributions in tumor and normal tissues. In this calculation, one must take into
consideration the fact that different kinds of radiation contributing to the total dose have dif-
ferent values of relative biological effectiveness1 (RBE). Furthermore, the biological boron dose
due to neutron capture by the boron-10 nuclei depends on the compound factor2 (CF) [Chu99].
This CF is related to the mode and route of drug administration, boron distribution within the
tumor, normal tissues, and even more specifically within cells, and even the size of the nucleus
within the target cell population all can influence the experimental determination of the CF
factor [Bar05]. CF, therefore, are fundamentally different from the classically defined RBE,
which is primarily dependent on the quality (i.e., LET) of the radiation administered [Bar05].
CF is strongly influenced by the distribution of the specific boron delivery agent and can differ
substantially, although they all describe the combined effects of alpha particles and lithium-7
ions. The CF for the boron component of the dose are specific for both the boron-10 delivery
1 Relative biological effectiveness is the ratio of the absorbed dose of a reference source of radiation (e.g.
X-rays) to that of the test radiation that produces the same biological effect [Bar05].
2 Some authors denominate this factor as compound biological effectiveness (CBE) factor.
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agent and the tissue [Bar05, Lev01, Chu99]. The compound factor and RBE make it possible to
add the different dose components and calculate the total dose, Dtotal, in a photon-equivalent
dose expressed in gray-equivalent (Gy-Eq) units [Chu99, Bar05]:
Dtotal = CFDboron 10
+ RBEnitrogenDnitrogen
+ RBEfast neutronDfast neutron
+ RBED (2.3)
Where each RBEi is the specific RBE for the radiation type i and Di is the absorbed dose of
radiation i.
Fractionation
The basis of fractionation in radiotherapy can be understood in simple terms. Dividing a dose
into a number of fractions spares normal tissues because of repair of sublethal damage between
dose fractions and repopulation of cells if the interval time is sufficiently long. At the same
time, dividing a dose into a number of fractions increases damage to the tumor because of
reoxygenation and reassortment of cells into radiosensitive phases of the cycle between dose
fractions1. The advantages of prolongation of treatment are to spare early reactions and to allow
adequate reoxygenation in tumors. Excessive prolongation, however, allows surviving tumor
cells to proliferate during treatment [Hal00]. As a summary of the basis of fractionation, here
comes the four R’s of radiobiology [Hal00]:
 Repair of sublethal damage
 Reassortment of cells within the cell cycle
 Repopulation
 Reoxygenation
The alpha particles produced in the 10B(n, )7Li reaction have an average LET of 200 keV/m
and at most, it takes only a few of them discharging their energy within a malignant cell to kill
it. They are equally as lethal to hypoxic cells, oxygenated cells, and nondividing cells [Bar92].
Sublethal damage (SLD) and potentially lethal damage2 (PLD) induced by BNCT are not sub-
ject to repair, whereas SLD and PLD produced by gamma photons and X-rays are repairable.
These properties are advantageous for the treatment of glioblastomas and melanomas in which
significant DNA repair may occur [Bar92].
Fractionation hardly moderates (if at all) the effects of high LET radiation. In BNCT, the
issue is much more complicated because of the mix of high and low LET radiation encoun-
tered [Gup03]. A further concern is the adequate delivery of boron-10 to all parts of the tumor.
1 The reassortment is the redistribution of cells throughout the phases of the cell cycle and this is relevant
because the radiosensitivity of mammalian cells varies throughout the cell cycle [Nia98]
2 According to IAEA, radiation damage to mammalian cells can be divided into three categories: (1) lethal
damage, which is irreversible, irreparable and leads to cell death, (2) sublethal damage, which can be
repaired in hours unless additional sublethal damage is added that eventually leads to lethal damage, and
(3) potentially lethal damage, which can be manipulated by repair when cells are allowed to remain in a
non-dividing state [Sun05]
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Since, in principle BNCT, delivers high LET radiation to tumor cells, fractionation affects nor-
mal tissues and tumor differently [Gup03]. The existence of low LET components in BNCT
may allow the delivery of higher doses, or add an additional factor of safety, to normal tissues
during a fractionated dose delivery. In the tumor, the most important gain from fractionation
is thought to be due to retargeting of the boron compound [Gup03].
Although, in theory, no advantages emerge from a fractionated protocol, several studies demon-
strate that this is not clear yet [Bar92, Gup94, Mor01, Gah89]. Moreover, the effect of different
treatment variables on the treatment time and tumor dose has been shown to be very signif-
icant. It has also been shown that the location of the maximum dose shifts significantly,
depending on some of the treatment variables, mainly the fractionation scheme used. These
results further emphasize the fact that dose prescription in BNCT is very complicated and
nonintuitive [Gup94]. Above all, the example depicted in figure 2.12 demonstrates the great
potential of BNCT and the hypothesis of considering and studying a fractionated protocol for
it.
Figure 2.12: Clinical appearance of a case in a clinical trial (mucoepidermoid carcinoma of
parotid gland). Before BNCT (left) and 22 months after the first BNCT treatment. Although it
can not be considered as a standard fractionation scheme, three BNCT treatments were used in
this case (the second treatment was one month after the first; the third was one year after the
first). After [Kat04].
2.1.5 Challenges
The success of BNCT depends on a number of parameters including tumor location and depth,
boron-10 content in tumor and normal tissues (more selective and effective boron-10 delivery
agents [Bar05]), and neutron fluence. Calculations have shown that 109 boron-10 atoms per
cell and thermal neutron fluences of 1012-1013 n cm 2 are needed [Bar92]. This high number
of boron-10 atoms is required for the radiation dose from the alpha particles to exceed that
delivered by the unavoidable background contributions of the capture reactions of hydrogen
and nitrogen [Bar92]. Theoretically, it should be possible with BNCT to increase significantly
and selectively the radiation dose delivered to tumors to levels higher than those achieved with
conventional therapy while simultaneously restricting the normal tissue doses to levels lower
than their tolerance [Bar92]. This will depend on the energy of the neutrons, dose rate, and
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fractionation [Bar92].
Also, the development of methods to provide semiquantitative estimates of tumor boron content
before treatment, improvements in clinical implementation of BNCT, and a need for random-
ized clinical trials with an unequivocal demonstration of therapeutic efficacy are other critical
issues that must be addressed [Bar05]. If these issues could be adequately addressed, then
BNCT could move forward as a treatment modality [Bar05].
Another challenge for BNCT is the ambiguity of published data as it was mentioned in sec-
tion 2.1.1. The BNCT community needs to, and is already in the process of, standardize each
aspect of the design and implementation of clinical trials. If this goal is achieved, it will allow
meaningful use of the available multi-institutional data. Only after some of these challenges
are met and all the data is sorted out, will it be possible to move ahead into Phase III clinical
trials [Gup03].
BNCT represents an extraordinary joining together of nuclear technology, chemistry, biology,
and medicine to treat cancer. Sadly, the lack of progress in developing more effective treatments
for high-grade gliomas has been part of the driving force that continues to propel research in
this field [Bar05]. BNCT may be best suited as an adjunctive treatment, used in combination
with other modalities, including surgery, chemotherapy, and external beam radiation therapy,
which, when used together, may result in an improvement in patient survival. Clinical studies
have shown the safety of BNCT. The challenge clinicians and researchers are facing is how to
get beyond the current impasse [Bar05].
2.2 Neutron imaging
2.2.1 Principles
Neutron radiography is a powerful nondestructive imaging technique that produces a two-
dimensional attenuation map of neutrons that have penetrated an object being examined [And09].
The method was initially developed after X-ray radiography, and the techniques share many
similarities in setup and practice. X-ray and neutron radiography are often complementary
techniques, especially when low-energy neutrons are used. X-rays interact with orbital elec-
trons and are strongly tied to the physical density of the examined object [And09, Par08].
Neutrons interact with the nucleus rather than its orbital electrons, so there is usually no tie
to the object’s electron density, but rather its elemental composition. Because the technique is
based on attenuation from a well-collimated beam, either scattering or absorption will result
in intensity variations to create an image [And09, Par08].
As it happens with X-ray, neutron imaging can also be thought to be three-dimensional (neutron
tomography).
2.2.2 Comparison with other imaging modalities
In section 2.2.1 some comparisons were already made between neutron and X-ray imaging.
Those two methods rely on different matter interactions (figure 2.13), therefore the information
that can be gathered from each imaging technique is distinct. To make this clear, some example
images are shown.
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Figure 2.13: X-ray and neutron cross sections for different elements. The sizes of the circles
symbolize the strengths of the scattering cross sections. After [And09].
Figure 2.14: Comparison of neutron (left) and X-ray (right) images. After [Ins].
Figure 2.15: Radiograph of a computer floppy disk using neutrons (left) and X-rays (right).
With neutrons it is possible to see the polymeric components clearly, while X-rays are sensitive
only to the metallic components. After [And09].
2.2.3 Neutron beamline requirements
A neutron radiography system consists of a neutron source, a moderator to thermalize the
neutrons, an aperture and a collimator to organize neutrons into a beam, and a detector to
visualize the image (figure 2.17) [And09].
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(a) Photograph of a printed circuit board. (b) X-ray image. Most contrast is given by
the metal pins.
(c) Neutron image. Most contrast is given
by plastic parts and the metal pins are
nearly transparent.
(d) Combination of both images. The X-
ray image was subtracted from the neutron
image.
Figure 2.16: Comparison and combination of X-ray and neutron images. After [Sch]
Figure 2.17: Illustration of a typical neutron imaging system. After [And09].
Energy
Neutron imaging requires neutron energies in the thermal/epithermal energy range (0.025 eV -
10 keV) [And09]. Thus some form of moderation is needed to slow down neutrons to this
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energy [And09]. Since the principle is the same, the materials depicted in section 2.1.3 are also
applicable in this case.
Collimation
Once low-energy neutrons are produced, they must be formed into a usable beam. Neutrons
are emitted and then scattered randomly in the moderator and, because of their neutral charge,
they cannot be focused like electrons [And09]. Those neutrons traveling in the desired solid
angle can, however, be selected by the introduction of a tube into or adjacent to the moderator.
This has the effect of allowing neutrons to stream down the tube axis toward the object being
radiographed [And09]. The walls of the collimator tube are lined with a neutron opaque
material having a high absorption cross section (such as boron, gadolinium, and cadmium),
which prevents background neutrons from entering and also reduces low-angle scattering within
the collimator [And09]. The most common collimator design is a divergent collimator (figure
2.18) with a small entrance aperture and a larger exit. This maximizes the neutron flux and
permits a larger field at the imaging plane [And09].
Figure 2.18: Divergent collimator of a neutron imaging system illustrating the collimator tube
length (L) and its aperture diameter (D). After [And09].
Exposure times
Although the exposure time depends on the facility characteristics, the reactor at the Institute
of Atomic and Subatomic Physics in Vienna has a thermal flux of 1:3105 n cm 2 s 1 and it
can have exposure times as low as 20 seconds per image [Ins]. This means that it is possible to
perform a set of measurements necessary for neutron tomography (about 200 images) within
a few hours [Ins].
2.2.4 Detectors
Since neutrons are neutral, they do not produce direct ionization events and detecting neutrons
must be based on detecting secondary events produced by nuclear reactions. These nuclear
reactions can be (n,p), (n,), (n,) or (n,fission), or by nuclear scattering from light charged
particles which are then detected [Kra88]. In table 2.5 some neutron detectors are listed along
with their efficiencies. There are three main classes of detectors for neutrons in general and for
neutron imaging in particular. They are [And09]:
 Scintillator and storage phosphor detectors
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 Gas detectors
 Solid-state detectors
Table 2.5: Typical values of efficiency for some common neutron detectors. The neutron detec-
tion efficiency is for neutrons with the specified energy striking the detector face at right angles.
Adapted from [Cra91].
Neutron Incident Neutron
active neutron detection
Detector type Size material energy efficiency (%)
Plastic scintillator 5 cm thick 1H 1 MeV 78
Liquid scintillator 5 cm thick 1H 1 MeV 78
Loaded scintillator 1 mm thick 6Li thermal 50
Hornyak button 1 mm thick 1H 1 MeV 1
Methane (7 atm) 5 cm diam 1H 1 MeV 1
4He (18 atm) 5 cm diam 4He 1 MeV 1
3He (4 atm), Ar (2 atm) 2.5 cm diam 3He thermal 77
3He (4 atm), CO2 (5%) 2.5 cm diam 3He thermal 77
BF3 (0.66 atm) 5 cm diam 10B thermal 29
BF3 (1.18 atm) 5 cm diam 10B thermal 46
10B-lined chamber 0.2 mg/cm2 10B thermal 10
Fission chamber 2.0 mg/cm2 235U thermal 0.5
Scintillator and storage phosphor detectors
A neutron scintillator is a material that absorbs neutrons and emits low-energy photons. The
scintillator is then coupled to an optical system to detect the photons created in the scintillator.
As the optical system changes, the detectors can be [And09]:
 Photographic scintillation detector : a photographic film is used to make the readout. This
solution has two disadvantages, low light collection efficiency and the need to change the
film to make the readout [And09]. More recently, the use of charge-coupled device (CCD)
cameras has transformed this technology into a competitive high resolution imaging sys-
tem [And09]. A typical system is depicted in figure 2.19
 Counting scintillation detectors: the light detection is made with photomultipliers [And09]
Another type of detector is the storage phosphors. These detectors are functionally similar to
scintillators, except that, instead of a prompt light emission, energy is stored. The phosphor is
read by photostimulation (typically by scanning with a laser), inducing light emissions (figure
2.20).
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Figure 2.19: Neutron imaging system with a CCD as optical system. Left : Neutrons hitting
the scintillator are converted into visible light that is collected on the CCD of a camera. Right :
Light-proofed box containing mirror, CCD optics, and camera. After [And09].
Figure 2.20: A gadolinium-157-based image plate accumulates energy from internal conversion
electrons produced in neutron capture in its storage phosphor. The image plate is transferred to
a reading system. A laser scans the image plate and photostimulates the release of blue photons
from the storage phosphor in the image plate. After [And09].
Gas detectors
In a gas detector, the radiation enters in a chamber filled with gas and produces ionization
events (e.g., neutron capture). Inside the chamber an electrical potential difference causes
the ions produced to accelerate and produce more ionization events (figure 2.21). This se-
quence of events repeats itself until the charge is detected by the plates responsible for the
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potential [Kra88, And09]. Common gas converters are 4He, 3He and BF3 (table 2.5).
Figure 2.21: Gas detector principle. After [Soc].
Solid-state detectors
If the charged particles from a neutron capture enter a semiconductor device, the resultant
ionized region will produce a pulse. If the pulse is large enough, the device becomes a neu-
tron detector that can be coupled to fast readout counting electronics. Potential advantages
of semiconductor detectors include high data rate, small size, and very low power require-
ments [And09].
2.2.5 Applications
There are several possible applications for neutron imaging. For example industrial research
and investigation, homeland security, and museologic studies, among others. The next set of
images shows some applications.
Figure 2.22: Three-dimensional reconstructions of parts of a fuel injector device. Metallic com-
ponents can be extracted or suppressed by image processing. After [And09].
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Figure 2.23: Neutron imaging applied to homeland security. Optical picture (left) and a neutron
image of an aircraft container (right). After [And09].
(a) Two smooth-polished metal sheets
brought by the police to Schillinger’s team,
which were originally car chassis numbers
plates.
(b) X-ray image.
(c) Neutron image. (d) Another neutron image with a different
color scale.
Figure 2.24: Another example of neutron imaging applied to homeland security. After [Sch]
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Figure 2.25: A Roman sword (photo in the middle) inspected with X-rays (upper image) and
thermal neutrons (lower image). After [Leh06].
2.3 Neutron activation analysis
The principle of activation analysis is that a particle (neutron, proton, alpha particle, etc.)
or photon (gammas, bremsstrahlung) induces a nuclear reaction in an atom of a target ele-
ment [Fil95]. The product of the reaction is detected and quantified by prompt photon or
particle emission or, more commonly, by its decay properties, if radioactive. For neutron ac-
tivation analysis (NAA), in which neutrons are used, several nuclear reactions are possible
depending on the target nucleus and the neutron energy [Fil95].
NAA is comprised by several different techniques:
 Instrumental neutron activation analysis (INAA): is the most commonly used technique
and is characterized by the quantification of the product radionuclide. This quantification
is dependent on its decay mode and half life and is done through high resolution gamma-
ray spectroscopy using Ge, Ge(Li) or Si(Li) detectors [Fil95]
 Radiochemical neutron activation analysis (RNAA): with some elements, or combination
of elements, an elemental separation from the sample is needed. This can be done before
irradiation or after, and also re-irradiation can be performed if needed [Fil95]
 Epithermal and fast neutron activation analysis (ENAA and FNAA): with some elements
can be advantageous to use epithermal or fast neutrons instead of thermal neutrons.
This can be done to take advantage of some resonance in the excitation function of some
elements (section 1.2) [Fil95]
 Prompt gamma-ray neutron activation analysis (PGNAA): this technique differs from the
other activation methods in that the prompt gamma-rays are measured rather than the
radioactive product [Fil95]
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Figure 2.26: Nuclear processes involved in prompt gamma-ray neutron activation analysis and
neutron activation analysis: neutron capture is immediately followed by emission of prompt
gamma-rays. The compound nucleus decays by beta emission followed by the emission of de-
layed gamma-rays. After [And09].
Figure 2.27: Example of prompt gamma-ray neutron activation analysis spectrum from an
estuarine sediment. After [And09].
Part II
Simulation studies
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Chapter 3
Validation of Geant4
Although several other models of physics processes are involved in the simulations (electro-
magnetic, optical, and decay, for example), the focus should be the hadronic models differences
because this work involves protons and neutrons. Therefore, three hadronic models were tested:
 Precompound model : this model was tuned during this work, since the code came origi-
nally from the Geant4 hadrontherapy example. The difference from the model used was
the cut values for electrons. All models together form a Geant4 physics list1 and the
hadronic options activated for the simulations were:
– Elastic Scattering for all the hadrons and ions
– Inelastic scattering: precompound + evaporation (generalized evaporation model) 2
for protons, neutrons, and pions
 QGSP_BIC_HP3: this package4 uses Geant4 Binary cascade (BIC) for primary pro-
tons and neutrons with energies below 10 GeV. Also, it has the high precision (HP)
neutron library to simulate the transport of neutrons below 20 MeV down to thermal
energies [CER]
 QGSP_BERT_HP5: this is another Geant4 package, which uses the Bertini cascade
for primary protons, neutrons, pions and kaons below 10 GeV. As the package name
indicates, it has also the high precision neutron library [CER]
3.1 Validation of (p,n) reactions
One of the possible applications of proton cyclotrons is neutron production through (p,n)
reactions. Validation of Geant4 aims at testing its accuracy in reproducing experimental data.
The work of Verbinski and Burrus was used to perform such validation [Ver69].
1 A physic list is a class which collects all the particles, physics processes and production thresholds needed
for the application [Wri09b]
2 See appendix C.2
3 Quark-gluon string precompound binary cascade high-precision neutron library
4 The term package is applied in this case because this is one of the many packages included with Geant4 that
assembles all necessary models (and the recommended for specific cases) in one package. The packages in
Geant4 can be initiated with only one command line in the main Geant4 file.
5 Quark-gluon string precompound Bertini high-precision neutron library
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3.1.1 Setup
Table 3.1: Proton stopping power and density of the target used. The value of proton stopping
power and density are from NIST database [Phy] and from WebElements [Win], respectively.
Target Proton stopping power Density
(MeV cm2 g 1) (g cm 3)
beryllium-9 22.75 1.848
Table 3.2: Quantities related to proton energy and target thickness. Here the initial proton
energy (Ep), the average proton energy in the target (hEpi), the loss of energy in the target (E),
and the calculated target thickness are presented. Adapted from [Ver69].
Target Ep hEpi E Target thickness
(MeV) (MeV) (MeV) (m)
beryllium-9 18.57 18.0 1.06 25.2
Figure 3.1: Setup used for Geant4 (p,n) reactions validation. Inside a perfect detector (spherical
surface with a 30 centimeters radius), at the reference origin, is placed a target with a thickness
of X (table 3.2). The proton source is localized at z =  20 cm. This setup was simulated in
vacuum and with an idealized pencil beam.
3.1.2 Results
In the first simulations with protons it was seen a shift of about 1% in the detected energy
against the expected energy. This was corrected by introducing a correction for relativist
3.1. Validation of (p,n) reactions 41
effects . Although this effect for deuterons and californium-252 is negligible due to the energies
involved, its simulations were also made with this correction. So, the neutron kinetic energy
was given by:
KE =
q
px2 + py2 + pz2 + nRM2   nRM (3.1)
Where KE is the neutron kinetic energy, px, py, and pz are the three neutron momentum
components, and nRM is the neutron rest mass (939.6 MeV/c2).
Beryllium-9
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Figure 3.2: Comparison of experimental and simulated double differential cross sections for the
9Be(p,n)9B reaction (0° <  < 5°).
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Figure 3.3: Comparison of experimental and simulated double differential cross sections for the
9Be(p,n)9B reaction (15° <  < 25°).
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Figure 3.4: Comparison of experimental and simulated double differential cross sections for the
9Be(p,n)9B reaction (35° <  < 45°).
3.1. Validation of (p,n) reactions 43
Neutron energy (MeV)
0 2 4 6 8 10 12 14 16 18 20
)
M
eV
×
sr
m
b
D
ou
bl
e 
di
ffe
re
nt
ia
l c
ro
ss
 s
ec
tti
on
 (
0
10
20
30
40
50
60
Verbinski and Burrus
QGSP_BERT_HP
QGSP_BIC_HP
Precompound
° < 65θ < °55
Figure 3.5: Comparison of experimental and simulated double differential cross sections for the
9Be(p,n)9B reaction (55° <  < 65°).
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Figure 3.6: Comparison of experimental and simulated double differential cross sections for the
9Be(p,n)9B reaction (75° <  < 85°).
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Figure 3.7: Comparison of experimental and simulated double differential cross sections for the
9Be(p,n)9B reaction (95° <  < 105°).
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Figure 3.8: Comparison of experimental and simulated double differential cross sections for the
9Be(p,n)9B reaction (115° <  < 125°).
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Figure 3.9: Comparison of experimental and simulated double differential cross sections for the
9Be(p,n)9B reaction (140° <  < 150°).
Neutron energy (MeV)
0 2 4 6 8 10 12 14 16 18 20
)
M
eV
×
sr
m
b
D
ou
bl
e 
di
ffe
re
nt
ia
l c
ro
ss
 s
ec
tti
on
 (
0
10
20
30
40
50
60
Verbinski and Burrus
QGSP_BERT_HP
QGSP_BIC_HP
Precompound
° < 175θ < °165
Figure 3.10: Comparison of experimental and simulated double differential cross sections for the
9Be(p,n)9B reaction (165° <  < 175°).
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3.1.3 Considerations
Simulations with beryllium-9
The simulations with beryllium-9 have shown how different each model is. To make comparisons
between each model an overall mean error was defined :
overall mean error =
1
9
graph9X
i=graph1
20X
j=1
jbinsimulated ij   binexperimental ijj
20
(3.2)
Where bin is defined as a group of data (in the case of figures 3.2 to 3.10 each unit of energy
is a bin).
The precompound model has demonstrated a good agreement with experimental data, with an
overall mean error of 1.11, showing, however, an excessively flat neutron energy distribution.
This means that some fluctuations in the experimental neutron energy were not verified with
this model, the most evident being the energy peak observed near the end of experimental
data.
The QGSP_BIC_HP package demonstrated results clearly not compatible with experimental
data. In all angles the simulated neutron energies did not describe the full energy range,
falling to zero much before the experimental ones. Although the overall mean error with
QGSP_BIC_HP was 0.74 this value was achieved due to the small errors in the higher angles.
The QGSP_BERT_HP package was the worst of all, with an overall mean error of 10.68.
Despite of this error, this package does not appear to have the same two problems encountered
in the two previous cases: (1) it seems to describe the fluctuations of the experimantal data
and (2) the neutron energy range is similar to the experimental one.
The decision of which model to use was between precompound model and QGSP_BERT_HP
due to the mentioned reasons. However, to make QGSP_BERT_HP package suitable to use,
one must find a constant to transform the simulated data to agree with the experimental
data. Using a trial and error approach, the constant that minimizes the QGSP_BERT_HP
package overall mean error is 1=6:61 with an error of 0.59. Besides the lower error compared with
precompound model, one of the features of Geant4 packages is the cpu optimization and this is
obvious by comparing simulation times in section C.2 and, therefore, the QGSP_BERT_HP
package will be the choice for simulating the 9Be(p,n)9B reaction. The next set of images shows
the double differential cross sections with the QGSP_BERT_HP package correction factor.
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Figure 3.11: Comparison between experimental and corrected-QGSP_BERT_HP-package sim-
ulated double differential cross sections for the 9Be(p,n)9B reaction (0° <  < 5°).
Neutron energy (MeV)
0 2 4 6 8 10 12 14 16 18 20
)
M
eV
×
sr
m
b
D
ou
bl
e 
di
ffe
re
nt
ia
l c
ro
ss
 s
ec
tti
on
 (
0
2
4
6
8
10 Verbinski and Burrus
QGSP_BERT_HP
° < 25θ < °15
Figure 3.12: Comparison between experimental and corrected-QGSP_BERT_HP-package sim-
ulated double differential cross sections for the 9Be(p,n)9B reaction (15° <  < 25°).
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Figure 3.13: Comparison between experimental and corrected-QGSP_BERT_HP-package sim-
ulated double differential cross sections for the 9Be(p,n)9B reaction (35° <  < 45°).
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Figure 3.14: Comparison between experimental and corrected-QGSP_BERT_HP-package sim-
ulated double differential cross sections for the 9Be(p,n)9B reaction (55° <  < 65°).
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Figure 3.15: Comparison between experimental and corrected-QGSP_BERT_HP-package sim-
ulated double differential cross sections for the 9Be(p,n)9B reaction (75° <  < 85°).
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Figure 3.16: Comparison between experimental and corrected-QGSP_BERT_HP-package sim-
ulated double differential cross sections for the 9Be(p,n)9B reaction (95° <  < 105°).
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Figure 3.17: Comparison between experimental and corrected-QGSP_BERT_HP-package sim-
ulated double differential cross sections for the 9Be(p,n)9B reaction (115° <  < 125°).
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Figure 3.18: Comparison between experimental and corrected-QGSP_BERT_HP-package sim-
ulated double differential cross sections for the 9Be(p,n)9B reaction (140° <  < 150°).
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Figure 3.19: Comparison between experimental and corrected-QGSP_BERT_HP-package sim-
ulated double differential cross sections for the 9Be(p,n)9B reaction (165° <  < 175°).
3.2 Validation of (d,n) reactions
Some proton cyclotrons are also capable of accelerating deuterons, which through (d,n) reac-
tions can be used to produce neutrons. The validation of Geant4 for the (d,n) reactions was
made against experimental published data. It was used the work of Weaver et al. [Wea73].
3.2.1 Setup
The setup for this validation was the same for the (p,n) reactions validation (section 3.1.1). In
table 3.3 deuterons energy and target thickness used for this validation are listed. This setup
was simulated in vacuum and with an idealized pencil beam.
Table 3.3: Deuteron energy (Ed) and target thickness for (d,n) reaction validation. Adapted
from [Wea73].
Target Ed Target thickness
(MeV) (m)
beryllium-9 8.8 53.57
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3.2.2 Results
Neutron energy (MeV)
0 2 4 6 8 10 12 14
)
M
eV
×
sr
m
b
D
ou
bl
e 
di
ffe
re
nt
ia
l c
ro
ss
 s
ec
tio
n 
(
0
20
40
60
80
100
° < 8.28θ < °0
Weaver et al.
QGSP_BERT_HP
QGSP_BIC_HP
Precompound
Figure 3.20: Comparison of experimental and simulated double differential cross sections for the
9Be(d,n)10B reaction (0° <  < 8.28°).
3.2.3 Considerations
It is difficult to analyze the graph depicted in figure 3.20 mainly because the experimental
data are not equally distributed per bin. Nevertheless, one conclusion can be easily drawn: the
precompound model and the QGSP_BERT_HP package are clearly not suitable for this ap-
plication. The QGSP_BIC_HP package seems to yield simulated data in the same magnitude
of the experimental ones. More considerations can not be drawn, not even trying a correction
factor for QGSP_BIC_HP package. Despite these constraints, the package QGSP_BIC_HP
will be used for 9Be(d,n)10B reaction simulations.
3.3 Verification of californium-252 decay
Unfortunately, Geant4 does not have a built-in decay mode for californium-252 in its libraries1.
Consequently, for this simulation the modelization of californium-252 decay mode was needed.
Since only neutrons and gammas can pass through the double capsule of this radionuclide2,
they are the ones that should be simulated.
Neutron energy was obtained with equation 1.9 with 100 keV intervals and within the range of
0.4 MeV to 10.0 MeV. Gamma emission energy was considered to be a Gaussian distribution
with an average of 0.87 MeV and a sigma of 0.020 MeV [Val99]. Both neutrons and gammas
1 See appendix C.2 for informations about the version used
2 Californium-252 is only available with a double encapsulation protection
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have an isotropic spatial distribution1.
3.3.1 Setup
Figure 3.21: Setup used for Geant4 californium-252 decay mode verification. Inside a perfect
detector (spherical surface with a 30 centimeters radius), at the reference origin, the source is
placed. This setup was simulated in vacuum.
3.3.2 Results
Table 3.4: Parameters given by the Gaussian fit of californium-252 energy spectrum (bottom
graph of figure 3.22).
Mean (MeV) Sigma (MeV)
Value 0:8700 0:0200
Error 5:424610 6 3:834210 6
Table 3.5: Californium-252 equivalent time-mass with the number of neutrons simulated.
Number of neutrons Californium-252 equivalent
simulated time-mass (gs)
6:40227106 2:767
1 Due to the encapsulation, this is not true, but for this study any eventual anisotropy is not an important
issue because (1) the focus of this work is the viability of implementing a neutron beamline and not studying
californium-252, and (2) the anisotropy is dependent on the californium-252 manufacturer due to different
materials and methods used to make the capsule [Eis88, Rao78, Vei09]
54 Chapter 3. Validation of Geant4
Neutron energy (MeV)0 1 2 3 4 5 6 7 8 9 10
N
or
m
al
iz
ed
 c
ou
nt
s 
pe
r 1
00
 k
eV
 (a
.u.
)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8 Simulated neutron energy
Theoretical distribution
Gamma energy (MeV)0.78 0.8 0.82 0.84 0.86 0.88 0.9 0.92 0.94 0.96 0.98
Co
un
ts
 p
er
 1
 k
eV
 (a
.u.
)
0
50
100
150
200
250
310×
Simulated gamma energy
Gaussian fit
Figure 3.22: Californium-252 energy modelization verification. The upper graph is the simulated
neutron energy with the theoretical spectrum yielded by equation 1.9. The bottom graph is the
simulated gamma energy with a Gaussian fit. The parameters given by the fit are depicted in
table 3.4
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Chapter 4
Implementation viability
4.1 Cyclotron beam energy and dispersion
4.1.1 Setup
In order to have a good correlation with the cyclotron studied, it is also important to simulate
the cyclotron port to better describe the experiment conditions. The setup used to perform this
simulation was the same depicted in figure 1.6, having in this case an additional perfect detector
(spherical surface with a 30 centimeters radius). The last target volume (aluminum) was placed
at the reference origin and the initial beam was a pencil beam. This setup was simulated in
vacuum. The table 4.1 summarizes the materials properties used in this simulation.
Table 4.1: Thicknesses and densities of the materials used in the simulation.
Thickness (mm) Density
Havar® 0.050 8.304 g cm 3
Gaseous helium 20.0 0.0001786 g mL 1
Aluminum 0.012 2.70 g cm 3
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4.1.2 Results
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Figure 4.1: Cyclotron beam energy and dispersion for protons. The upper graph is the detected
energy and the bottom graph is the angular dispersion. Both graphs were fit with a Gaussian
function and the results are presented in table 4.2.
Table 4.2: Resulting parameters of the Gaussian fits depicted in figure 4.1.
Energy (MeV) Angle (degrees)
Mean 17:66  1:3410 5  2:8510 1  6:6610 3
Sigma 5:5510 2  9:3110 6 1:08  2:6510 3
4.2. Thick target optimization 59
Deuterons
Energy (MeV)6.5 6.6 6.7 6.8 6.9 7
Co
un
ts
 p
er
 1
0 
Ke
V
0
0.2
0.4
0.6
0.8
1
1.2
610×
Simulated beam energy
Gaussian fit
Angle (degrees)0 1 2 3 4 5 6 7 8 9 10
Co
un
ts
 p
er
 0
.1
 d
eg
re
es
0
5
10
15
20
25
310×
Simulated beam dispersion
Gaussian fit
Figure 4.2: Cyclotron beam energy and dispersion for deuterons. The upper graph is the detected
energy and the bottom graph is the angular dispersion. Both graphs were fit with a Gaussian
function and the results are presented in table 4.3.
Table 4.3: Resulting parameters of the Gaussian fits depicted in figure 4.2.
Energy (MeV) Angle (degrees)
Mean 6:74  1:3510 5  2:6610 1  1:6810 2
Sigma 5:9710 2  9:6510 6 2:26  7:1010 3
4.2 Thick target optimization
For thick target optimization, three different yields were considered, a total yield, a yield at
60°, and a yield at 89°. The total yield is related to the total neutron production in 4 sr.
The yields at 60° and 89° are proportional to the neutrons produced in a forward solid angle of
60° and 89°, respectively. These different units can give a good idea of the neutron direction,
and, if significant differences appear, it is possible to choose the optimal target thickness to get
the maximum forward neutron beam. These simulations were perfomed in vacuum.
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4.2.1 Reaction (p,n)
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Figure 4.3: Thick target thickness optimization for the 9Be(p,n)9B reaction with yield 60°and
yield 89°. Both curves were fit with a grade 3 polynomial function.
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Figure 4.4: Thick target thickness optimization for the 9Be(p,n)9B reaction with total yield.
The curve was fit with a grade 3 polynomial function.
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Table 4.4: Optimal target thicknesses for the 9Be(p,n)9B reaction given by the grade 3 polynomial
fit parameters. These fits are depicted in figures 4.3 and 4.4.
Thickness (mm)
Total yield 2:0630:1863
Yield 60° 2:0670:1919
Yield 89° 2:0310:1987
4.2.2 Reaction (d,n)
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Figure 4.6: Thick target thickness optimization for the 9Be(d,n)9B reaction with total yield.
The curve was fit with a grade 3 polynomial function.
Table 4.5: Optimal target thicknesses for the 9Be(d,n)9B reaction given by the grade 3 polynomial
fit parameters. These fits are depicted in figures 4.5 and 4.6.
Thickness (m)
Total yield 274:9267:777
Yield 60° 278:5779:106
Yield 89° 273:5375:889
4.3 Cyclotron-based neutron beamline
The choice of materials and their thicknesses for all implementation simulations was made
based on literature and published data. The main influences were [Lev01, Mau98, Lud97].
The criterion used for choosing the targets thicknesses was the mean of the values given in
tables 4.4 and 4.5 for protons and deuterons, respectively.
According to the manufacturer, the cyclotron has a proton beamline with about 80% of the
particles inside 10 mm at 30 cm after cyclotron port (section 1.4.2). The simulation study
depicted in section 4.1 has shown that, with a sigma of 1.08, 80% of particles are inside 10
mm at 20.72 cm after the double-window system. This was the value used since the Havar®,
gaseous helium and aluminum were also simulated in each setup. For deuterons, 70% of the
deuterons are inside 10 mm at 12.67 cm, and this was also the value used for the same reason
as in the protons case.
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All simulations with an implementation setup were performed in air.
Table 4.6: Densities of the materials used in the simulated setups.
Material Density (g cm 3)
Aluminum 2.70
Aluminum fluoride 2.88
Aluminum oxide 3.97
Lead fluoride 7.75
Heavy water 1.1056
Boron carbide 2.52
Bismuth 9.78
Cadmium 8.65
4.3.1 Setups
In all setups, the length of the collimator and the length of the shield of collimator exit is
30 cm and 10 cm, respectively. The purpose of the shield of collimator exit is to prevent the
passage of neutrons through the walls of the collimator, therefore imposing to the neutron
beam a path throughout the collimator aperture. This shield should be made with a good neu-
tron absorber, such as boronated compounds and polyethylene enriched with lithium fluoride,
preferably lithium-6 flouride [Lev01].
Figure 4.7: Scheme of setup type 1.
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Figure 4.8: Scheme of setup type 2.
Table 4.7: Characteristics of the setups simulated for (p,n) and (d,n) reactions. The setup type
column refers to figures 4.7 and 4.8. Only setup 7 was simulated with a deuteron beamline.
Moderator Moderator
Setup Setup 1 2 Reflector
number type [thickness (cm)] [thickness (cm)] [thickness (cm)]
1 1 Aluminum [30] Aluminum fluoride [20] Lead fluoride [10]
2 2 Aluminum oxide [50] — Lead fluoride [10]
3 1 Aluminum [30] Aluminum fluoride [20] Lead fluoride [15]
4 1 Aluminum [36] Aluminum fluoride [24] Lead fluoride [10]
5 1 Aluminum [36] Aluminum oxide [24] Lead fluoride [10]
6 2 Heavy water [50] — Lead fluoride [10]
7 1 Aluminum [30] Aluminum fluoride [20] Lead fluoride [15]
Table 4.8: Materials and their thicknesses used for gammas filter, thermal neutrons filter, and
shield of collimator exit.
Gamma filter Thermal neutrons filter Shield of collimator exit
[thickness (cm)] [thickness (cm)] [thickness (cm)]
Bismuth [10] Cadmium [0.05] Boron carbide [the same as reflector]
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4.3.2 Results
(a) Image with protons only.
(b) Image with neutrons only.
Figure 4.9: Simulation of a beam with 10000 protons and with a setup type 1 (setup number 1).
Both images are from the same simulation, protons being shown in the top, and neutrons in the
bottom image.
66 Chapter 4. Implementation viability
(a) Image with protons only.
(b) Image with neutrons only.
Figure 4.10: Simulation of a beam with 10000 protons and with a setup type 2 (setup number
2). Both images are from the same simulation, protons being shown in the top, and neutrons in
the bottom image.
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Table 4.9: Epithermal, fast, and thermal neutrons density flux, and gamma density flux obtained
with all (p,n) and (d,n) simulations.
Epithermal Fast Thermal
Setup neutrons neutrons neutrons Gamma
number flux flux flux flux
density density density density
( 10
5 n
(150Acm2s)) (
105 n
(150Acm2s)) (
103 n
(150Acm2s)) (
106 n
(150Acm2s))
1 7.4 4.7 0 11.3
2 4.6 1.3 0 6.7
3 13.1 6.6 0 12.4
4 5.4 2.5 0 9.6
5 4.9 1.2 0 9.3
6 0.9 0.6 7.9 2.0
7 1.2 0.3 0 0.9
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(b) Gamma energies.
Figure 4.11: Energy spectrum of both neutrons and gammas with setup 1. These results were
obtained with 1.4109 simulated protons.
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Figure 4.12: Energy spectrum of both neutrons and gammas with setup 2. These results were
obtained with 500106 simulated protons.
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Figure 4.13: Energy spectrum of both neutrons and gammas with setup 3. These results were
obtained with 500106 simulated protons.
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Figure 4.14: Energy spectrum of both neutrons and gammas with setup 4. These results were
obtained with 500106 simulated protons.
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Figure 4.15: Energy spectrum of both neutrons and gammas with setup 5. These results were
obtained with 500106 simulated protons.
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Figure 4.16: Energy spectrum of both neutrons and gammas with setup 6. These results were
obtained with 500106 simulated protons.
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Figure 4.17: Energy spectrum of both neutrons and gammas with setup 7. These results were
obtained with 200106 simulated deuterons.
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4.4 Californium-252-based neutron beamline
4.4.1 Setup
Figure 4.18: Scheme of the setup used for californium-252 simulations.
Table 4.10: Characteristics of the setup simulated with californium-252.
Moderator 1 Moderator 2 Reflector
[thickness (cm)] [thickness (cm)] [thickness (cm)]
Aluminum [30] Aluminum fluoride [20] Lead fluoride [10]
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4.4.2 Results
(a) Image with gammas only.
(b) Image with neutrons only.
Figure 4.19: Californium-252 decay simulation with the setup depicted in figure 4.18 and about
21 decays simulated. Both images are from the same simulation, gammas being shown in the top,
and neutrons in the bottom image.
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Table 4.11: Epithermal, fast, and thermal neutrons density flux, and gamma density flux ob-
tained with the californium-252 setup (figure 4.18).
Epithermal Fast Thermal
neutrons neutrons neutrons Gamma
density density density density
flux flux flux flux
(n=(cm2gs)) (n=(cm2gs)) (n=(cm2gs)) (n=(cm2gs))
3.6 1.6 0 4.1
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Figure 4.20: Energy spectrum of both neutrons and gammas for simulation with californium-
252. These results were obtained with 7106 simulated neutrons and considering a source with
initial activity.
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4.5 Implementation and operational costs
Both cyclotron-based neutron beamline and californium-252-based neutron beamline have ad-
vantages and disadvantages in terms of costs. The setup construction for each case is very
similar, therefore the costs are nearly the same with some advantage for californium-252-based
beamline due to lower neutrons energies and less moderating material needed. Probably, com-
paring with the other costs, this difference is negligible. However, this implementation analysis
is not considering the acquisition of a californium-252 source, whereas the cyclotron is already
available at ICNAS. Californium-252 can be bought or be loaned. The loan has some advan-
tages since the initial cost is inferior and the manufacturer is responsible for replacing the
source after the loan period (in general five years) or if any capsule defect or damage is de-
tected. The disadvantage of loaning is the existence of a loan fee that goes from about $3000 to
about $10000 depending on source mass. Also, the acquisition of a source has some handling
and transport fees [Mar99]. The estimated cost for a californium-252 source is detailed in table
4.12, without considering fees.
Table 4.12: Estimated cost for a californium-252 source. Adapted from [Mar99].
Date Number of Requested 252Cf Estimated
(month/year) sources mass per source (g) cost
12/98 1 0.2 $7400
08/98 1 6 $9200
03/99 1 10 $10600
05/99 1 50 $13600
11/98 1 300 $14200
08/98 1 8000 $23000
01/99 2 27000 $51700 (single source $34800)
07/99 2 50000 $80800 (single source $44500)
The operational cost of the cyclotron is around 400e/h [Alv10c] and the californium-252-based
neutron beamline does not have any operational cost (not considering staff and consumables
in both cases). This difference in the two solutions is the key for choosing between them. If
the neutron beamline is to be used intensively (i.e., for long time periods) californium-252
becomes a more affordable solution, if not, the cyclotron is the obvious choice. It is important
to consider the decay of californium-252 and to quantify the intensities needed to determine
its useful lifetime. Another cost issue is between the use of protons and deuterons. Although
the deuterium source is more expensive than the hydrogen source, it seems that this difference
is insignificant compared with the cyclotron power consumption [Alv10d].
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Chapter 5
Conclusions and future work
A neutron beamline is an added value to a cyclotron-based facility, since it has a wide range of
applications such as basic research, radiobiological and material science studies, and homeland
security. The main aim of this thesis work was to provide a first scientific and financial viability
analysis of the implementation of a neutron beamline assembled at a low-energy cyclotron ma-
chine, which included the specificity of achieving thermal and epithermal neutron flux densities
appropriate for radiobiological studies (i.e., with energies below 10 keV).
Before a first-setup cost estimation could be put forward, an effort of estimating by means of
Monte Carlo the neutron production yield achievable with an 18-MeV cyclotron-based proton
beam was necessary in order to allow estimating with acceptable accuracy the amount and
type of material needed for reaching the main goal: a neutron radiobiological setup.
With this objective set, the Geant4 package was chosen as a simulation toolkit. Although
Geant4 shows a growing acceptance in the scientific community, due to the ground-breaking
aspect inherent to this thesis work, an initial emphasis was dedicated to a thorough, first-step
simulation and corresponding validation against published experimental results regarding neu-
tron yield. For this, a thin 9Be target was subject by simulation to a pencil-shaped proton
beam, with the results of the reaction 9Be(p,n)9B being collected and compared to exper-
imental data. Three different physical models/packages were tested independently, namely
the precompound model, the QGSP_BIC_HP package, and the QGSP_BERT_HP package.
All models/packages agreed with experiment in terms of the order of magnitude of absolute
double-differential cross-sections, with errors inferior to 20% being obtained in all cases, a
remarkable achievement in terms of nuclear physics. Due to the better agreement obtained
with the QGSP_BERT_HP package, all following simulations regarding first-setup optimiza-
tion made use of this physics package. Namely, optimization studies were performed regarding
(1) the double-window system cyclotron-port made of successive Havar®-Helium-Aluminum
materials, (2) 9Be thick-target optimization in terms of neutron yields, and (3) six different
moderator/collimator setups, with simulations results showing that the thickness of the reflec-
tor material in the neutron-beam collimator can optimize the epithermal flux density by a factor
of 2, reaching 106 neutrons/(150Ascm2) after only first educated-guesses regarding the
input of moderator thicknesses.
The same conclusions apply to the efforts presented through the remaining scientific fields
described in this thesis: the use of beams of deuterons was equally investigated, together with
the possibility of using a spontaneously-fissing californium-252 source. In the case of deuteron
beams, validation against thin-target 9Be targets were performed, as well as simulations for
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thick-targets, a double-window-system-based cyclotron port, and one full moderator/collimator
setup.
The results obtained with these first and preliminary simulations show that the flux density
is not enough for using in BNCT clinical trials/treatments, unless boronated compounds are
improved. However, the flux density achieved can give input to the BNCT main problem:
the development and testing of new boronated compounds. Moreover, flux densities in the
order of 106 neutrons/(150Ascm2), as are the ones obtained in this work, can be used for
radiobiological studies. Also, such beam permits the implementation of neutron imaging and
neutron imaging activation analysis.
Finally, the simulation of a californium-252 source is not provided by default within Geant4.
Therefore, software was constructed within this thesis that allowed introducing fission-physics
modelling within Geant4, followed once again by the full simulation of moderaror/collimator
setup.
Comparing a californium-252-based neutron beamline with a cyclotron-based one, it can be
seen that the former is more disadvantageous. That is due not only to logistic issues (it is not
possible to ’turn off’ a radioactive source) but also, and mainly, to its high cost, since it is
necessary a large mass of californium-252 to produce the required fluxes.
Deuterons should, in theory, yield higher flux densities than protons according to the double
differential cross sections of the 9Be(d,n)10B reaction. This was not verified in this work, which
was unexpected and must be reviewed if an implementation is considered. In order to carry out
such review, one must start by collecting more experimental double differential cross section
data to make a more accurate validation of Geant4 for (d,n) reactions.
It is important to point out that all simulation/analysis software prepared in the framework of
this thesis is now ready for fast and detailed setup optimization by making use of Coimbra’s
Milipeia high-performance computing cluster. The use of this infrastructure, planned to be
available within days, will allow the simulated statistics collected so far, presented throughout
this thesis, to be increased by about a factor 100 for each day of simulation burden.
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Appendix A
Stopping power
Charged particles lose energy in matter by their electro-magnetic interactions with atomic
electrons. This process is called energy loss by ionization. This change in energy per unit
distance traversed is called dE=dx, stopping power or Bethe-Bloch equation. The ionization
loss depends on the speed of the particle as well as properties of the medium. At small speeds,
dE=dx is inversely proportional to the square of the speed. At relativistic speeds, dE=dx passes
through a minimum and then grows logarithmically [Roh94].
This equation has different forms because of the many corrections that can be introduced.
According to Krane, the Bethe-Bloch equation is given by [Kra88]:
dE
dx
=

e2
40
2
4z2NAZ
mc22A

ln

2mc22
I

  ln  1   2   2 (A.1)
Table A.1: Variables and values of the Bethe-Bloch equation according to [Hag02] and [Kra88].
Symbol Definition Units or value
dE
dx energy loss MeV g
 1 cm2
A atomic mass of medium g mol 1
NA Avogadro’s number 6.0221367(36)1023 mol 1
 density of medium g cm2
ze charge of incident particle
Z atomic number of medium
mc2 electron rest energy 0.51099906(15) MeV
I mean excitation energy eV
c velocity of the particle m s 1
0 electric constant C2 N 1 m 2
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Appendix B
Havar®
Havar® was originally developed in the late 1940’s by the Hamilton Watch Company as an ’un-
breakable’ mainspring material [Rob03]. As watches moved from spring to battery power, thin
Havar® strip found a second life in high strength, non-magnetic, corrosion resistant pressure
sensing diaphragms for process control equipment [Rob03].
According to the technical sheet of Havar® [HPM], this material is a heat treatable cobalt
base alloy that provides very high strength. The alloy has excellent corrosion resistance and is
non-magnetic. Applications have included pressure diaphragms, power springs, gap spacers in
magnetic heads, and target foils in nuclear physics [HPM].
Table B.1: Nominal composition of Havar®. After [HPM].
Element Elemental percentage
Cobalt 42.0%
Chromium 19.5%
Nickel 12.7%
Tungsten 2.7%
Molybdenum 2.2%
Manganese 1.6%
Carbon 0.2%
Iron Balance
Table B.2: Physical properties of Havar®. After [HPM].
Property Value
Density 8.304 g cm 3
Melting point 1480℃
Electrical resistivity @ R. T. 92.0 
 cm
Thermal expansion coefficient (0℃ to 50℃) 12.5  10 6 ℃ 1
Thermal conductivity 13.0 W m 1 K
Magnetic attraction none
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Appendix C
Software and hardware used
C.1 Hardware
For this work, three different machines were used, however the major part of the work was
done on machine 1 (table C.1).
Table C.1: Machines used to perfom the simulations
CPU Number of cores RAM Memory
Machine 1 Intel® Core™ 2 Duo T7500 2.20GHz 2 4 GB
Machine 2 Intel® Core™ 2 Quad Q6600 2.40GHz 4 4 GB
Machine 3 Intel® 2140 1.60GHz 2 1 GB
C.2 Geant4 simulation toolkit
Geant4 is a public, costless software toolkit that simulates the passage of particles through mat-
ter [Ago03, All06] and relies on Monte Carlo technique to accomplish that. It is a very flexible
solution with innumerous models of physics processes in a wide range of energies [Ago03]. It
can cover hadronic, electromagnetic and optical interactions and has libraries to a large set
of materials, elements and long-lived particles [Ago03, All06]. It is designed to be used as
object-oriented language and is implemented in C++ [Ago03].
The hadronic interactions with Geant4 are divided in three major groups: (1) cascade state,
(2) pre-equilibrium state, and (3) equilibrium state. Each state has its own models, but in
some cases it is not necessary to have a model for each state. For example, interactions at
low energy (< 100 MeV) can be modelized without the cascade phase [Wri09a, Ago03]. The
cascade state describes the intra-nuclear projectile-nucleon and nucleon-nucleon interactions
after the projectile enters the nucleus. The two main models for this phase are the Bertini
cascade and binary cascade. The main code for modelization of pre-equilibrium state is the
precompound model that takes a nucleus from a highly-excited set of particle-hole states down
to equilibrium energy by emitting protons, neutrons, deuterons, tritium nuclei, helium-3 nuclei,
and alphas [Wri09a]. The final phase, the equilibrium state, is known also as nuclear evapora-
tion or nucleus de-excitation phase. After the pre-equilibrium phase, the nucleus is supposed
to be left in an equilibrium state, in which the excitation energy is shared by a large number
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of nucleons. If the excitation energy is higher than the separation energy1, it can still eject
nucleons and light particles (deuterons, tritium nuclei, helium-3 nuclei, and alphas) [Gea09].
The generalized evaporation model (GEM) is an example of an evaporation model.
Geant4 performance
Table C.2: Geant4 performance measured in machine 1 with different setups and reactions.
Setup number Number of events Simulation Geant4 physics
(if applicable) (or particles) time (s) used
4 1M 277.92 QGSP_BERT_HP
7 1M 684.96 QGSP_BIC_HP
californium-252 3.2104 neutrons 167.99 QGSP_BERT_HP
C.3 Other software
Besides Geant4 9.3 other software was used.
 Operating system: openSuse 11.2 64-bit version (Linux kernel 2.6.31.12)2
 Library for high energy physics: CLHEP version 2.0.4.5.
 C++ compiler: GCC version 4.4.1
 Geant4 visualization system: HepRApp version 3.15.0
 Data analysis: ROOT framework version 5.26/00 and QtiPlot version 0.9.7.14
 Error propagation software: LAB Fit version 7.2.48
 Numerical computation software: Octave version 3.2.4
1 Separation energy is the energy needed to remove a nucleon or other particle from a nucleus
2 Other versions of openSuse were also used, but almost all simulations were done with openSuse 11.2 64-bit
version
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